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BIOLOGICAL ACTIVITY AND CONFORMATIONAL ANALYSIS OF 
NIKKOMYCINS AND THEIR ANALOGS.
by
Eduardo Krainer 
Adviser: Professor Fred Naider
Nikkomycins and polyoxins are peptidyl nucleoside 
antibiotics produced by Streptomyces species. They are 
potent inhibitors of chitin synthetases from pathogenic 
fungi, and polyoxins have been used in Japan for many years 
as agricultural fungicides and for insect control. Since 
chitin synthetase is not found in mammals and both families 
of antibiotics are not toxic, these inhibitors are 
potentially attractive for clinical use. Unfortunately 
these compounds seem to have only a fungistatic action, and 
they are not used clinically at present.
A procedure for efficiently obtaining nikkomycins X 
and Z of very high purity from crude antibiotic is 
described. These nikkomycins are very intractable to 
separation by conventional chromatography. Our protocol 
relies on the use of reversed-phase HPLC with a reactive 
mobile phase (aqueous sodium bisulfite). A polar bisulfite 
addition product is formed with nikkomycin X, but not
V
nikkomycin Z, within the column bed. This drastically 
changes the mobility of the former antibiotic and leads to 
the full resolution of both compounds. The bisulfite 
addition compound can be easily reverted to nikkomycin X. 
Recovery yields are in the order of 65-80 %.
Five tripeptide analogs (1-5, Table 7) and four 
dipeptide analogs (9-12, Table 8 ) of polyoxins and 
nikkomycins with expected enhanced toxicity toward C, 
albicans were synthesized, and their biological properties 
tested against various strains of this yeast. The 
dipeptides were designed as double-targeted drugs, able to 
inhibit chitin synthetase and/or release a toxic amino acid 
upon hydrolysis. One of the tripeptides, L-leucyl- 
nikkomycin X (3), behaved as a prodrug, releasing a toxic 
peptide upon intracellular hydrolysis. None of the 
synthetic antibiotics proved more toxic than nikkomycin.
The conformation of nikkomycin X in aqueous solution 
was examined by using nuclear Overhauser effects as well as 
by pH titration studies in which ^-nmr shifts were 
monitored. The antibiotic exhibits a very flexible 
structure, with coexisting syn and anti conformations of 
the nucleoside moiety. Conformational shifts of the pentose 
ring, and also along the C4/-C5/bond, occurred during the 
titration. The studies in aqueous solution were undertaken
as a preamble to studies of the antibiotic bound to chitin 
synthetase and perhaps to peptide permeases of c.  albicans. 
NOe measurements were carried out on nikkomycin X in the 
presence of fungal membranes containing active enzymes, in 
an effort to obtain preliminary conformational information 
for the bound molecule.
vii
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Thesis plan.
Chapter I: The introduction starts with a review of the 
current knowledge of the chemical structure of the 
cell-wall of Ca ndida albicans. Chitin synthesis is 
discussed as a target for antifungal drugs. The known 
natural inhibitors of chitin synthetase, polyoxins and 
nikkomycins, are presented and their mechanism of action, 
as well as their limitations, are discussed. The current 
knowledge of the peptide transport system of C. albicans is 
discussed in some detail, since it is utilized by the 
chitin synthetase inhibitors for permeation into the cell. 
Finally, data from the literature as well as our own 
observations on the stability of the nikkomycins under 
hydrolytic conditions is examined.
Chapter II: The introduction to this chapter is a brief 
discussion on the methods in the literature for the 
purification and separation of the nikkomycins. It is 
shown how a mixture of nikkomycins X + Z was isolated from 
crude antibiotic by reversed-phase HPLC. Attempts at 
resolving this mixture are discussed, and the concepts 
behind chemochromatography are presented. 
'Chemochromatography: its use for the separation of 
nikkomycins X and Z' describes the development of this 
novel mode of reversed-phase HPLC and its success in the
xii
analytical and preparative separation of nikkomycins X and 
Z. This work was published in Analytical Biochemistry,
1987, with R. K. Khare, Fred Naider, and Jeffrey M. Becker.
Chapter III; The introduction to this chapter is a review 
of the polyoxin analogs that have been reported in the 
literature. This review is separated into two sections, 
dipeptide analogs and tripeptide analogs, in order to make 
the presentation more clear. The effects of different 
chemical modifications on the toxicity of the analogs 
against c. albicans are discussed. When there is no data 
available, the toxicity against phytopathogenic fungi is 
presented instead. 'Synthesis and biological evaluation of 
dipeptidyl and tripeptidyl polyoxin and nikkomycin analogs 
as anticandidal prodrugs' was submitted in a modified 
version to Journal of Medicinal C h emist ry  in 1990, with 
Fred Naider and Jeffrey M. Becker, and was accepted for 
publication. This work tries to extend previous concepts 
and introduces novel approaches to the problem of 
anticandidal drug design. Finally, the appendix presents 
data showing nikkomycin to be resistant to hydrolysis by 
peptidases from C. albicans.
Chapter IV: In the first section, the problems and 
advantages of different approaches for obtaining 1H-nmr 
spectra of nikkomycin X in aqueous solution are discussed,
xiii
and the results of preliminary experiments are shown. The 
second section, 'Conformational studies of nikkomycin X in 
aqueous solution' is a work published in Biopolymers in 
April 1990 with Fred Naider and Jeffrey M. Becker. In it, 
the conformational behavior of nikkomycin X in solution is 
explored. Appendix B expands the conformational studies of 
the ribose ring from the previous section, presenting data 
used in the calculations, as well as drawings of the 
conformers. The next section introduces the concept of 
transferred nuclear Overhauser effect; finally, in the last 
section, preliminary results of nmr studies on nikkomycin 
in the presence of active enzymes from c. albicans 
membranes are presented.
Note: The references are grouped at the end of the last 
section, last Chapter. Sections that have also been 
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Chapter I. Introduction and background.
Chitin synthesis and peptide transport in Candida albicans.
Candida albicans is an imperfect dimorphic yeast 
usually associated with warm-blooded animals as a harmless 
and asymptomatic commensal. In immunologically weakened 
hosts, however, C. albicans can manifest itself as a 
virulent pathogen. Despite its being the most common and 
most serious fungal pathogen of man, many important aspects 
of its biology are still not understood (1 ).
The cell-wall of C. albicans, as that of 
Sa ccharomy ces cerevisiae, is composed mainly of p-glucans, 
mannoproteins, chitin and lipids (2,3). The main structural 
component of the c.  albicans wall is p-glucan (48-60%) 
containing I->3 and l-»6 linkages (3,4). Mannoprotein 
(20-23%)(3) is distributed throughout the cell-wall but 
also accumulates on the surface and next to the plasma 
membrane (1). p-(l-»6 ) Glucan may be cross-linked to 
mannoprotein (5). Chitin (1-3 %)(3) is located mainly in 
the bud scar in c. albicans yeast cells, but smaller 
amounts are distributed throughout the inner wall (6,7). 
Chitin, a linear polysaccharide composed of p-(l-»4)-linked 
N-acetylglucosamine units, is an essential component for 
maintenance of the structural stability of the cell-wall
2
and for the formation of primary septa in budding cells 
(8 ). The N-H and C=0 groups in adjacent chains of chitin 
associate by hydrogen bonding. The very strong association 
between chains accounts for the formation of fibrils, as 
well as for the insolubility of chitin in water (9, 10). 
Covalent linkages between chitin and glucans have only been 
investigated recently (1 , 1 1 ), and there is evidence for a 
glycosidic bond at position 6 of N-acetylglucosamine and 
position 1 of the glucose in the p-(l-»6 )-glucan.
Chitin synthetase, the enzyme responsible for the 
last step in chitin biosynthesis, is located predominantly 
in the plasma membrane (12). Its substrate, UDP-GlcNAc, 
approaches the membrane from the cytoplasmic face and 
transfers the GlcNAc through the synthetase to a chain of 
chitin which, as it grows, is simultaneously extruded (9). 
No energy source other than that provided by the free 
energy of hydrolysis of the bond between the amino sugar 
and UDP appears to be necessary (9). Chitin synthetase is 
present in the cell as a zymogen and can be activated in 
vitro by proteolysis. Chitin synthetase from s .  cerevisiae 
has been isolated in its active form by co-precipitation 
with its product, chitin (13). Interestingly, the chain 
length of chitins synthesized in vivo, with a membrane 
preparation, or with the purified enzyme, is the same in 
all cases (somewhat more than 100 GlcNAc units). This
3
suggests that chitin synthetase itself is capable of 
determining the length of the chitin chains (13)'.
Chitinase is a soluble enzyme that shows maximum 
activity during c. albicans yeast growth (14). It is 
probably required for localized hydrolysis of wall chitin 
and for the softening of walls which appears to be 
necessary for growth (9).
It has been found recently (15, 16, 17) that there are 
two chitin synthetase activities in S. c e r e v i s i a e . Chitin 
synthetase I, which is not essential for cell growth and 
seems to be just a repair or auxiliary enzyme, is the main 
in vitro measurable activity. Chitin synthetase II, on the 
other hand, is essential for synthesis of chitin and septum 
formation. Very recently (18), evidence was also presented 
for the existence of at least two chitin synthetases in C. 
a l b i c a n s. A gene coding for one of the chitin synthetases 
in C. albicans (chitin synthetase I, a protein of 776 amino 
acids) was cloned by expression in S. cerevisiae. This 
candidal gene is homologous (37% amino acid identity) to 
the gene coding for chitin synthetase I in s.  cerevisiae.
It is not known whether chitin synthetase I in c, albicans 
is also non-essential for growth.


















Figure 1 Substrate and inhibitors of chitin 
synthetase.
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important antifungal drugs, since the structural 
polysaccharide chitin is not present in mammalian cells.
The most effective known inhibitors of fungal chitin 
synthetase, polyoxins (19) and nikkomycins (20) (Figure 1), 
are not used clinically at present. It has been shown, 
however, that a mixture of nikkomycins X and Z (see Table 2 
for structures) is effective in prolonging the survival 
time of mice experimentally infected with C. albicans (21), 
but these antibiotics seem to have just a fungistatic 
action. This behavior correlates with the existence of 
large discrepancies (2-3 orders of magnitude) between 
reported MIC values for inhibition of fungal growth and Ki 
values for the inhibition of chitin synthetase in vitro. 
This discrepancy is due to the failure of the nikkomycins 
and polyoxins to reach their target within the cell. 
Translocation of these antibiotics into the cell takes 
place through peptide permeases (22,23). All polyoxins and 
nikkomycins have at least one peptide bond, and the 
membrane transport system of c.  albicans recognizes these 
antibiotics as peptides (23). The cause of the failure of 
these inhibitors to accumulate intracellularly appears to 
be a low rate of permeation, and not their putative 
metabolism by the yeast (see below and Chapter III).
Peptide uptake in C. albicans takes place through an 
active peptide transport mechanism, with passage of the
6
intact peptide across the cell membrane. The possibility of 
hydrolysis in the membrane, with vectorial transport, 
cannot be ruled out in some strains of c. albicans (24). In 
general, separate amino acid and peptide transport systems 
seem to exist, but the evidence for this is not conclusive 
and the question will probably remain open until genetic 
studies of peptide transport are undertaken (24). 
Independent dipeptide and oligopeptide permeases have been 
suggested to be present in c.  albicans WD 18-4 (25), but 
this point is not very clear (24). A common transport 
system has been proposed for the uptake of both di- and 
tripeptides by c. albicans 6406 (26), and two distinct 
transport systems, one accepting both di- and tripeptides 
and the second more specific for trimethionine, were 
postulated in the case of C. albicans ATCC 26278 (27). 
Although it is possible that different C. albicans strains 
may possess different peptide transport systems, evidence 
to date seems to support the presence of a general system 
which recognizes di- and tripeptides (and perhaps also 
tetrapeptides). A second system (or more than one) does not 
have an appreciable affinity for most dipeptides (24).
Knowledge of the side chain specificity of the 
different peptide permeases can be exploited in the design 
of anticandidal drugs. At present, there is not enough data 
to discuss the specificity of individual transport systems
7
in c. a l b i c a n s. It is generally accepted that peptides 
containing lysine are not well transported into this yeast, 
whereas hydrophobic peptides are excellent substrates for 
the permeases (24) (nevertheless see Chapter III). On the 
other hand, a-N-acylated peptides are usually transported 
into C. albicans, whereas peptide esters are not (24). A 
dipeptide with a d residue at either the amine or carboxyl 
terminus is non transportable, but the situation with 
oligopeptides is less clear (24). It appears that some 
tripeptides containing d residues, such as 
d-Met-l-Met-l-Met (25), or Arg-D-X-Phe where X is an amino 
acid (28), are transported. The d residue cannot be located 
at the carboxyl terminus. On the other hand, at present, no 
peptide with more than one d-residue is known to be 
recognized by the transport system of c. al bicans (24). The 
above information was incorporated into the design of 
modified polyoxins and nikkomycins with improved 
permeability (see Chapter III).
8
Polyoxins.
The polyoxins are a family of peptidyl nucleoside 
antibiotics produced by Streptomyces cacaoi. Their 
structures (see Table 1) were elucidated in the sixties by 
Isono's group (19). The unusual amino acids found in these 
compounds have the l  configuration and are, from the amino 
terminus:
a)S-Carbamoyl polyoxamic acid,
( 3 S ,4S)-5-[(aminocarbonyl)oxy]-3,4-dihydroxy-L-norvaline, 
or in the case of polyoxin G, carbamoyl deoxypolyoxamic 
acid, where the hydroxyl group at the p position is absent,
b) Polyoxin C, or
1- (5'-amino-5'-deoxy-p-D-allofuranosyluronic
acid)-5-hydroxymethyluracil. The hydroxymethyl group in












(25)-3-ethylideneazetidine-2-carboxylic acid, has an 
ethylidene group which is trans with respect to the 
carboxyl group. The aHylic character of the a hydrogen 
accounts for the facile racemization of this compound when 
it is obtained by acidic hydrolysis of polyoxins (19).
Polyoxins D, E, and F have been converted (29) to 
polyoxins L, M, and K respectively, by decarboxylation of 
the 5-carboxyuracil moiety. This reaction was carried out 
in two steps: first, the nucleophilic addition of sodium 
bisulfite to the 5,6-double bond accompanied by 
decarboxylation, and then elimination of the sulfonate 
group by alkali.
Some of the constituent amino acids of the polyoxins 
have already been synthesized. The synthesis of carbamoyl 
polyoxamic acid is described in (30), and the synthesis of 
polyoxin c-type amino acids in (31-33). The preparation of 
a precursor of polyoximic acid is described in (34).
10






COR 2 JL II/  2o ^ >HK'..
*1 e 2 *3
c h2o h - rCO,H
OH
c h2o h 06 OH
c o2h OH OH




c o 2h 0^ H




















0> L  C CH,OH  biologically
HN 1 . j  inactive
'  1 CH20H Ny ~ Ĵ  biologically
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Table 1 Polyoxins (19, 29).
Polyoxins are structurally similar to uridine 
diphosphate N-acetyl glucosamine (Figure 1), the substrate 
of chitin synthetase. They are competitive inhibitors of 
this enzyme, the inhibition constant Ki being remarkably 
constant for chitin synthetases from different sources. Ki
11
values are in the 10"6-10"7 M range (9). Polyoxins enter c. 
albic ans through a peptide transport system (35, 23). Thus, 
di- and tripeptides present in the growth media antagonize 
the anti-C a ndi da activity of polyoxins. Furthermore, 
polyoxin-resistant mutants of C. albicans exhibit 
cross-resistance to bacilysin and other toxic di- and 
tripeptides (23).
The free carboxyl group at C-5', as well as the free 
(positively charged) amino group are required for chitin 
synthetase inhibition (36-38). Thus acylation or alkylation 
of the C 2"-amino group, as well as amidation of the 
carboxyl group, results in inactive or poor enzyme 
inhibitors (38-40). Further aspects of the effects of 




Nikkomycins are peptidyl nucleoside antibiotics 
structurally related to polyoxins (Table 2). Like the 
polyoxins, they are potent competitive inhibitors of chitin 
synthetase and use the peptide transport system for entry 
into yeast cells (41, 42). Their isolation from 
fermentation broths of Streptomyces tendae, as well as 
their chemical structures have been described in the late 
seventies by a German group (20, 43-46). In 1980 Isono's 
group reported the detailed structures of a new family of 
antibiotics which they called neopolyoxins A, B, and C 
(47-49). The neopolyoxins were produced by streptomyces 
cacaoi subsp. asoensis. These antibiotics turned out to be 
identical to nikkomycin X, an oxidized form of nikkomycin 
X, and nikkomycin Z, respectively. Despite some initial 
confusion about whether or not there were stereochemical 
differences between the constituent amino acids of the 
nikkomycins and the neopolyoxins (48, 49), it is now clear 
that these antibiotics are identical (50). Neopolyoxins A 
and C will be referred to as nikkomycins X and Z.
The amino acids present in the nikkomycins have the l  
configuration, are biologically inactive in their free 
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Table 2 Nikkomycins (47, 51-54).
a) nikkomycin D,
HO" v  ' 3
(25,35,45)-2-amino-4-hydroxy-4-(5-hydroxy-2-pyridyl)-3-
14
-methyl butyric acid, or variations in which the phenolic 
hydroxyl group or the methyl group are missing, or the 
nitrogen atom in the pyridine ring is in a different 
position or absent (see Table 2).
b) Nikkomycin C, 1-(5'-amino-5'-deoxy-p-D- 
-allofuranosyluronic acid)uracil,
HO OH
and nikkomycin Cx, 1-(5'-amino-5#-deoxy-p-
-D-allofuranosyluronic acid)4-formyl-4-imidazoline-2-one
It has been shown that in the biosynthesis of the 
polyoxins the pyrimidine nucleoside moiety is formed by 
condensation of uridine and phosphoenol pyruvate (55, 56). 
It is very likely that the nucleoside moiety of nikkomycin 
C is formed from uridine and that a subsequent ring 
contraction of the uracil to the imidazolinone ring then 
takes place (49). This kind of rearrangement has been 
previously described (57), and was used for the conversion 
of nikkomycin C into nikkomycin Cx (49).
c) Glutamic acid or homoserine are present as carboxy 





The synthesis of the N-terminal amino acid of the 
nikkomycins has been carried out by different groups. A 
non-stereoselective synthesis of the N-terminal amino acid 
of nikkomycin B, where the key step is a 1,3-dipolar 
cycloaddition, is described in (44). Further refinements of 
this synthesis leading to nikkomycin D are described in 
( 5 8 ) . Two stereoselective syntheses of the N-terminal amino 
acid of nikkomycin B have been achieved, one by Banks e t  
a l .  ( 5 9 ) ,  and another by Melnick e t  a l . ( 6 0 ) ,  who used an 
intramolecular [4 + 2]-cycloaddition reaction.
An important point to be considered when studying the 
biology of these antibiotics, or when one has to manipulate 
them, i.e. for purification, is their stability toward 
chemical and enzymatic hydrolysis. The peptide bond in 
polyoxin D is resistant to hydrolysis by peptidases from c. 
a l b i c a n s (61). There is no previous report, to our 
knowledge, on the stability of nikkomycins toward 
degradation by fungal peptidases. This latter point will be 
further addressed in Chapter III. Nikkomycins X and Z are 
fairly stable in aqueous solution at below neutral pH, but 
are rapidly degraded under alkaline conditions. Nikkomycins 
K x and 0X, in comparison, have been shown to be stable at 
pH 7 and 8 ( 5 2 ) . It has been proposed that anchimeric
16
assistance is the reason for the unusual instability of 






Data from the literature on the hydrolysis of 
nikkomycins, as well as our own results, are summarized in 
Table 3. Only dipeptide nikkomycins are considered. The 
































Bx TFA IN 100°C 1 hr nik Cx,3, 4, 5.
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X pH 5.5 20°C 8 day 18 HPLC 52
pH 7.0 20°C 4.7daj 50 HPLC
pH 8.0 20°C 4.6day 50 HPLC
Kx pH 5.5 20°C 30 day 47 HPLC
pH 7.0 20°C 30 day 35 HPLC
pH 8.0 20°C 30 day 15 HPLC
Yield (%) Comments Ref






20°C 30 day 17 HPLC
pH 7.0 20°C 30 day 50 HPLC
pH 8.0 20°C 30 day 55 HPLC
X pH 7.23 37°C 44 hr 50 HPLC
z pH 7.23 37°C 44 hr 50 HPLC







Chapter II. Purification of nikkomycins X and Z. 
Introduction.
Crude nikkomycin was obtained as a gift from Bayer 
Pflanzenschutz Leverkusen. This material contained a 
mixture of nikkomycins X and Z ( ~ 48%) and small amounts 
of other nikkomycins, as well as extraneous materials 
(salts, pigments, etc.). The purification of the crude 
material using reversed-phase HPLC (high-performance liquid 
chromatography) was attempted, in order to obtain 100 mg 
amounts of nikkomycins X and Z for biological and chemical 
work.
The original purification of nikkomycins X and Z by H. 
Hagenmaier et a l ., and specifically the separation of these 
two major antibiotic components of St reptomyce s 
fermentation broths, employed derivatization with dimedone 
and column chromatography on cellulose, as well as 
treatment with an alkylamine resin and further purification 
by HPLC using an RP-8 column (20). These methods sacrifice 
one component to obtain the other, and the reported yields 
are extremely low.
Another approach for the separation of nikkomycins 
(62, 63) has utilized reversed-phase HPLC with a RP-8
20
column, eluting with a combination of step and linear 
gradients with 30 mM ammonium formate buffer (pH 3.75) and 
1 mM heptanesulfonic acid in water and in methanol. The 
heptane sulfonic acid acts as a lipophilic counter-ion.
This was used as a quantitation method of nikkomycins in 
fermentation broths. Although nikkomycins X and Z are 
separated from other components, it would not be practical 
to scale up these conditions for the preparative 
purification of the nikkomycins because the counter-ion, 
heptanesulfonic acid, would be difficult to remove. 
Furthermore, baseline separation between nikkomycins X and 
Z was not achieved and the little resolution of these 
antibiotics would be lost in the scale-up. It is 
interesting that the authors (63) stated that 
chromatographic separation of nikkomycins that differ only 
in the nucleobase is difficult, almost impossible.
Purification of nikkomycins.
Reversed-phase packings, as well as the use of 
lipophilic ion-pairing reagents, have been increasingly 
popular for the analytical and preparative HPLC of peptides 
(64-68). The reversed-phase packings consist of silica gel 
to which a hydrocarbon, usually a chain of 4, 8 or 18 
carbon atoms, has been chemically attached. Partitioning of 
the solute occurs between the hydrophobic stationary phase
21
and a polar aqueous mobile phase. Being able to use aqueous 
solvents is very advantageous in processing polar 
non-solvent extractable compounds. Trifluoroacetic acid is 
widely used as an anionic ion-pairing reagent in the 
reversed-phase HPLC of peptides because its low boiling 
point allows for easy removal during freeze-drying. 
Furthermore, Ci8 reversed-phase chromatography using 
trifluoroacetic acid / water as the mobile phase has been 
successfully applied to the purification of natural and 
synthetic polyoxins (69, 70).
Attempts to purify the nikkomycins from the crude 
fermentation product using a TFA 0.05% mobile phase and a 
pBondapak Ci8 (Waters) stationary phase resulted in 
isolation of a mixture of nikkomycins X and Z. Figure 2 
shows analytical chromatograms at different concentrations 
of TFA. The major peak corresponds to the mixture of 
nikkomycins X and Z. The resolution of these components 
could not be increased by varying the concentration of TFA 
(from 0 to 0.10% ). Although the higher concentrations led 
to increased retention and marginal resolution (not seen in 
the figure), the high acidity is detrimental to the column 
(69). The increase in retention times appears to be due to 
ion pairing with protonated amino groups, as well as to an 
ion suppression effect on the carboxylic acid (65, 71) . A 











Figure 2 Analytical chromatogram of crude nikkomycin, with 
various amounts of TFA in the eluant. Support: p- 
Bondapak C18 (30cmx3.9mm) (Waters). Flow rate:
1.40 mL/min. X :254 nm. Retention times in minutes.
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of retention times with the addition of small amounts of 
TFA and then increased retention as more TFA is added, has 
been described for small unrelated peptides (65).
257 mg of pure nikkomycins X + Z were recovered from 
500 mg of crude antibiotic when the conditions shown in 
Figure 2, at 0.05% TFA, were scaled-up for preparative 
work. The 1H-nmr spectrum of this mixture is shown in 
Figure 3. The mixture is 75:25 nikkomycin X / nikkomycin Z,
as estimated from the relative areas of peaks such as the
ones at 6 7.72 (s, H-5, nik X), 9.24 (s, CHO, nik X) and 
5.68 (d, H-5, nik Z), 7.46 (d, H-6, nik Z).
Since nikkomycin X has an aldehyde group, it should in
principle be possible to form a derivative which could be 
separated from nikkomycin Z and then reversed to nikkomycin 
X. Sodium bisulfite has been used extensively for the 
separation of carbonyl compounds from other materials and 
was the obvious reagent choice. However it should be noted 
that nikkomycins are non-extractable water-soluble 
materials, and a bisulfite derivative of nikkomycin X would 
also be water soluble and more polar.
First attempts at resolving the nikkomycin X + Z 
mixture consisted of dissolving it in a saturated solution 
of NaHS03 in H 20 and injecting onto the reversed-phase C18
^*»"|iy<» 11 "^V î V i u
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Figure 3 200 MHz 1H-nmr spectrum of nikkomycin X + Z in DMSO-dg.
Tip angle: 30°;Relaxation delay: 4 sec;Reference: internal TMS.
to■t*
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column, with H 20/TFA as eluant. Interestingly, three 
different peaks could be clearly distinguished in the 
resulting chromatogram (see Figure 4). The first large 
peak, coming with the solvent front, is NaHS03. The second 
peak, with retention time of 3.52 min is presumably the 
nikkomycin X bisulfite addition compound. Some at first 
sight odd or unexpected features of this chromatogram are 
immediately apparent: a) the baseline between the second 
and third peak is somewhat above the rest of the baseline 
and has a positive slope, and b) the third peak, which 
would on first thought correspond to nikkomycin Z, the 
minor component (25%), is actually much larger than the 
second peak. This can be explained by noting that the 
bisulfite addition compound is in equilibrium with the free 
aldehyde,
and its decomposition, catalyzed by the acid present in the 
eluant, occurs in the column as the run proceeds. Thus, the 
third peak contains some nikkomycin X, and the elevation of 
the baseline observed between the second and the third peak 
is caused by nikkomycin X, which is formed gradually and 
migrates at a slower rate than the addition compound.
OH 0
The rate at which the chemical reaction occurs in the 











Analytical chromatogram of nikkomycin X + Z dis­
solved in aqueous NaHS03. Eluant: TFA 0.005%. 
Support: p-Bondapak C18 (30cmx3.9mm) (Waters).
Flow rate: 1.40 mL/min. A :254 nm. Retention times 
in minutes.
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final chromatogram. If the rate of decomposition of the 
bisulfite addition compound were very slow as compared to 
the rate at which the solutes move in the column, good 
separation would be achieved: the third peak would only 
consist of nikkomycin Z, and the baseline between the 
second and third peak would be flat. Conversely, one can 
imagine that if the rate of decomposition were very fast, 
the second peak (RT = 3.52 min) would completely disappear 
and the third peak would consist of the original mixture of 
nikkomycins X and Z. The actual chromatogram seen (Figure 
4) corresponds to an intermediate case, where the rates of 
reaction and of migration are comparable.
In actuality the rate of formation of the bisulfite 
adduct under conditions compatible with the chromatographic 
run is much faster than the rate of decomposition; taking 
advantage of this, the separation of the two nikkomycins 
can be achieved. This will be shown in the manuscript which 
follows.
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Chemochromatoaraphv: its use for the separation of 
nikkomycins X and Z.
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Chemochromatography: Its Use for the Separation of Nikkomycins X and Z1 
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A novel mode of reversed-phase high-performance liquid chromatography in which the 
mobile phase reacts chemically with the compounds to be separated was developed. Nikkomy- 
cin X and nikkomycin Z, two natural isomeric nucleoside peptide antibiotics, move as a single 
peak on a C , 8 reversed-phase column using an aqueous trifluoroacetic acid mobile phase.
Addition of sodium bisulfite (1.0%) to the mobile phase results in the formation o f a polar 
bisulfite addition product with nikkomycin X, but not with nikkomycin Z, inside the HPLC 
column. This type of reactive chromatography, or chemochromatography, led to the analytical 
and preparative separation o f  nikkomycins X and Z which are normally very intractable to 
separation by conventional chromatographic techniques, o  1987 Academic Press, inc.
K e y  W o r d s : chemochromatography; nikkomycin; nucleoside peptide antibiotics; reversed- 
phase HPLC techniques; NMR.
Nikkomycins, nucleoside peptide antibi­
otics produced by Streptomyces tendae, have 
potential value as therapeutic agents and 
pesticides (1-6). As a result o f the structural 
resemblance of the nikkomycins to uridine 
diphosphate-A'-acetylglucosamine, the natu­
ral substrate o f  chitin synthetase, these anti­
biotics are potent inhibitors o f this enzyme 
in both fungi and arthropods (7-10).
Previous attempts to separate nikkomycin 
X (1) and nikkomycin Z  (2) (two major bio­
logically active components o f Streptomyces 
fermentation broths) (Fig. 1) have utilized 
column chromatography on cellulose (3) and 
reversed-phase chromatography on an RP-8 
column (9,11). In all cases it was extremely 
difficult to separate 1 from 2 without sacrific­
ing one of the components. Some resolution 
o f nikkomycins X and Z was obtained using 
analytical HPLC (3,11), but these conditions
1 This work was supported by grants from the Na­
tional Institute o f  Allergy and Infectious Diseases 
(AM  4387 and AI-42631) and the PSC-BHE Awards 
Program o f CUNY.
could not be scaled up for the preparative 
separation o f these antibiotics since baseline 
separation was not achieved and the coun­
terion, heptanesulfonic acid, would prove 
difficult to  remove. Indeed investigators 
stated that separation o f nikkomycins which 
differ only in the nucleobase is difficult, al­
most impossible (9). With trifluoroacetic 
acid as the ion-pairing agent, we found that 1 
and 2 moved as a single unresolved peak.
The chromatographic modes which use a 
chemical reaction to selectively influence the 
mobility o f the sample, and which we call 
collectively chemochromatography, tradi­
tionally use a reactive stationary phase. Such 
is the case for the AgNOj-impregnated silica 
gel plates for olefinic samples, or the borate- 
impregnated silica gel for complexing glycol 
compounds (12). To separate 1 and 2 we de­
cided to use a reactive mobile phase. Specifi­
cally, we used an additive in the mobile 
phase o f  our reversed-phase HPLC system 
which would react with 1 (an aldehyde) but 
not with 2, reasoning that mobility changes 
accompanying such a reaction might make 
the separation possible.
Reprinted by permission of 
the publisher
0003-2697/87 $3.00
Copyright C  1987 by Academic Press, Isc .










Fig. 1. Structure of nikkomycins. Compounds 1, 2, and 3 are nikkomycin X, nikkomycin Z, and the 
bisulfite addition compound of nikkomycin X, respectively.
The desirable characteristics for this reac­
tion “in the column” are: (i) The reaction 
should be quantitative or nearly quantita­
tive. (ii) Its rate has to be very fast as com­
pared to the rate at which the compounds of 
interest move in the column so that the reac­
tion is complete in the very first portion of  
the column bed. (iii) The chromatographic 
mobility o f the derivative formed has to be 
different from the mobility o f the unreacted 
compound, (iv) From a preparative point of 
view, the reaction should be reversible, so 
that the original material can be recovered 
easily.
In this communication we report the suc­
cessful analytical and preparative separation 
of 1 and 2 using chemochromatography. Our 
procedure employs sodium bisulfite as the 
component o f the mobile phase which rap­
idly reacts with 1 forming a derivative with 
modified chromatographic properties.
MATERIALS AND METHODS
A Waters Associates (Milford, MA) HPLC 
system consisting of an M-45 solvent deliv­
ery unit, a U6K universal liquid chromato­
graph injector, a Waters Lambda-Max 
Model 481 spectrometer, and a Waters 
M730 data module was used for analytical 
separations. All separations were accom­
plished using a jtBondapak C)8 colum n  
(Waters) (particle size, 10 /mi; length, 30 cm; 
internal diameter, 3.9 mm).
Preparative separations were carried out
on a Waters Prep LC/system 500 instrument 
equipped with a refractive index detector. Ei­
ther a Waters One-Inch Semiprep column (1 
in. x  1 ft) packed with Waters preparative 
C|g-column packing material (particle size, 
55—105 urn) or a Waters Prep PAK-500/C|8 
cartridge (80-#tm mean particle size, 30 X 5.7 
cm) was used for purifications.
TFA2 (Aldrich, Milwaukee, WI) was of re­
agent grade and was used without purifica­
tion. The sodium bisulfite used (Fisher Sci­
entific Co., Fair Lawn, NJ) is a mixture of 
sodium bisulfite (NaHSOj) and sodium  
me/a-bisulfite (Na2S20 5) (assay as S 0 2 not 
less than 58.5%). The solutions were pre­
pared with glass-distilled water, filtered (Mil- 
lipore, 0.45 nm), and deaerated under vac­
uum before acidification. All concentration 
percentages are expressed as weight per vol­
ume. Activated carbon (Aldrich) used for de­
salting was o f nucleotide desalting grade and 
was slurry-packed after degassing the slurry 
under vacuum. Crude nikkomycin (~48%  1 
+  2) was obtained from Bayer Pflanzen- 
schutz Leverkusen.
'H NMR spectra at 200 MHz were ob­
tained on a Brucker spectrometer and were 
run at 25°C. Reported chemical shifts are 
relative to TMS or DSS3 as internal refer-
2 Abbreviations used: TFA, trifluoroacetic acid; TMS. 
tetramethylsilane; DSS, sodium 3-(trimethylsilyl)-l-pro- 
panesulfonate; RT, retention time; MIC, minimum in­
hibitory concentration.
3 Used for samples run in D 2Q.
31
CHEMOCHROMATOGRAPHY OF NIKKOMYCINS X AND Z
ences. Optical rotations were determined on 
a Perkin-Elmer Model 141 polarimeter. For 
elemental analyses, freeze-dried samples 
were further dried under vacuum over P20$ 
at 65 °C, for 44 h. Elemental analyses were 
performed by Galbraith Laboratories, Knox­
ville, Tennessee.
Purification o f  nikkomycin. In order to ob­
tain a mixture o f pure 1 and 2 from commer­
cial nikkomycin, 500 mg o f crude antibiotic 
was dissolved in 15 ml o f  aqueous TFA 
(0.25%), injected onto the Prepak-500/Ci8 
preparative column, and eluted with TFA 
(0.05%). Fractions were monitored using an­
alytical HPLC (Fig. 2). The fractions con­
taining the peak at RT 8.15 min were pooled 
and freeze-dried. A TFA salt (257 mg) was 
obtained in this way. ‘H NMR analysis 
showed this material to be a 75:25 mixture of 
1 and 2. Specifically in DMSO-tfk 1 exhibited 
singlets at 7.72 ppm (H-5) and 9.24 ppm 
(CHO) whereas 2 exhibited doublets at 5.68 
and 7.46 ppm for H-5 and H-6, respectively. 
The relative areas under these resonances 
were used to estimate the content o f isomers 
1 and 2.
Fig. 2. Analytical chromatogram o f crude nikkomy­
cin, using a fiBondapak C ia support. The eluant is 
CF 3C O 2H  (0.05%), the flow rate was set to 1.40 ml 
m in'1, and the detector was adjusted in the absorbance 
units mode at 254 nm. Retention times are in minutes.
Fig. 3. (a) Analytical and (b) preparative chemochro- 
matograms for a 1 +  2  mixture, using a Cu reversed- 
phase support. The eluant is water containing NaHSOj 
( 1.0%) and CF3CO2H (0.005%). In (a) the flow rate was 
set to 1.40 ml min* 1 and the detector was adjusted in the 
absorbance units mode at 290 nm. In (b) the flow rate 
was 50 ml min ' 1 and 50 mg of nikkomycin were in­
jected. Detection o f  refractive indexes relative to the sol­
vent. Retention times are in minutes.
Pure nikkomycin X and Z were recovered 
by dissolving 50 mg o f the mixture of 1 and 2 
in 1.5 ml o f distilled water and injecting it 
onto the 1-in. C,8 reversed-phase column, 
using a freshly prepared solution o f N aH S03 
(1.0%) and TFA (0.005%) (w/v) in water as 
the eluant. The column was previously equil­
ibrated with the same mobile phase. Figure 3 
shows both the analytical and the preparative 
chromatograms.
The fractions corresponding to 2 (peak 
with RT 7.52 min, Fig. 3a, and RT 9.7 min, 
Fig. 3b) were pooled and immediately de­
salted by percolating the solution through a 
column of activated carbon. Approximately 
1 ml bed/mg o f nikkomycin Z was used. The 
column was washed with water until no 
N aH S03 was present in the effluent. An at­
tempt to recover 2 by eluting with ace- 
tone:water (40:60) was unsuccessful, but, 
after rewashing the column with water, 2 
could be eluted with methanol:water:con- 
centrated ammonium hydroxide (80:20:0.1). 
After concentration and freeze-drying 6.2 mg 
o f 2 was obtained.
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NM R. 0.78 (3H, d, J  = 7.1 Hz, 
Me-3"), 2.72 (1H, m, H-3"), 4 .2 -4 .6  
(H-2',3',4',5',2"), 5.13 (1H, d, J  = 2.9 Hz, 
H-4"), 5.86 (1H, d, J  = 5.2 Hz, H-l'), 5.87 
(1H, d, /  = 8.0 Hz, H-5), 7.45 (2H, m, 
H-3"',4"'), 7.69 (1H, d, J  = 8.0 Hz, H-6), 8.08 
(1H, broad, H-6").
Elemental analysis. Found: C, 41.54; H, 
5.36; N, 12.30%. Calculated for C2oH25O io- 
N j-4.5  H20: C, 41.67; H, 5.94; N, 12.15% 
W d c = +25.0 (c 0.1, H20 )
The fractions corresponding to the bisul­
fite addition compound o f nikkomycin X (3) 
(large peak with RT 3.65 min, Fig. 3a, and 
RT 4.7 min, Fig. 3b) were pooled, acidified 
with dilute HC1 to pH 2.5, degassed under 
vacuum, reacidified, and concentrated under 
vacuum, maintaining the pH constant at 2.5 
with dilute HC1. In order to regenerate free 1 
from 3 the solution was diluted and concen­
trated several times under vacuum at pH 2.5. 
Alternatively 1 could be recovered from 3 by 
bubbling nitrogen through the solution for a 
few hours, while keeping the pH at 2.5. This 
transformation was followed by HPLC (TFA 
(0.10%) as the eluant) and stopped when 
complete. The concentrated solution was fi­
nally desalted by injection in the 1-in. C |8 
reversed-phase column, using TFA (0.10%) 
in H20  as the eluant. Pure nikkomycin X 
(29.5 mg) was obtained after concentration 
and freeze-drying.
NMR. C 150-* 0.60 (3H, d, J  = 7.0 Hz, 
Me-3"), 2.57 (1H, m, H-3") 3 .9 -4 .4  
(H-2',3',4',2"), 4.65 (1H, dd, H-5'), 4.95 (1H, 
d, J  = 2.7 Hz, H-4"), 5 .48(1H, d, J =  5 .0 Hz, 
H -l'), 7.31 (1H, dd, J  = 8.5 and 2.2 Hz, 
H-4"'), 7.36 (1H, d, J  = 8.5 Hz, H-3"'), 7.72 
(1H, s, H-5), 8.09 (1H, dd, J  = 2.2 and 0.8 
Hz, H-6"'), 8.0-8.2 (3H, NHJ), 9.13 (1H, d, J  
= 7.8 Hz, CONH), 9.24 (1H, s, CHO), 10.2 
(broad, ArOH), 11.22 (1H, s, NH-3).
Elemental analysis. Found: C, 36.87; H, 
3.72; N, 8.85; F, 14.71%. Calculated for 
C20H2jO 10N 5 -2T F A .3H 2O: C, 37.07; H, 
4.28; N, 9.01; F, 14.66%. [a&5#c = +16.0 (c 
0.1, H20 ).
RESULTS AND DISCUSSION
Trifluoroacetic acid has been shown to be 
a very useful anionic ion-pairing reagent in 
the reversed-phase HPLC o f  peptides 
(13-15). The increase in retention times ob­
served at low concentrations of TFA in water 
is apparently due to ion-pairing with proton- 
ated amino groups and/or to an ion suppres­
sion effect in the carboxylic acid functionali­
ties (13,16). The low boiling point o f TFA 
allows its easy removal during freeze-drying.
Attempts to purify 1 and 2 from a crude 
fermentation product using a trifluoroacetic 
acid 0.05% mobile phase resulted in isolation 
of a mixture of these antibiotics. As seen in 
Fig. 2 ,1  and 2 move as an asymmetric unre­
solved peak, RT 8.15 min. The resolution of  
these components could not be further in­
creased by varying the trifluoroacetic acid 
concentration (0-0.10% , w /v). Although 
higher concentrations o f the acid (0.10%) led 
to increased retention on the column and 
some additional resolution (data not shown), 
this concentration o f acid slowly deactivated 
the reversed-phase column. Sodium bisulfite 
is also not stable in high concentrations o f  
acid. A minimum retention time (4.28 min) 
was observed at a trifluoroacetic acid con­
centration o f approximately 0.01%; below 
this concentration the mobility o f the pepti- 
dyl-nucleoside antibiotics decreases and in 
pure water 1 and 2 move as an unresolved 
peak which tails badly. The trifluoroacetic 
acid concentration used for further separa­
tions was chosen to maximize the retention 
time o f  the antibiotics without destroying ei­
ther the column or the sodium bisulfite. For 
this purpose the concentration region be­
tween 0 and 0.01% trifluoroacetic acid was 
most appropriate and 0.005% acid worked 
very well.
Separation o f 1 from 2 was carried out by 
reversed-phase chromatography in the pres­
ence o f  sodium bisulfite. The analytical and 
preparative chemochromatograms for the 1 
+  2 mixture are shown in Fig. 3. After a
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Fig. A. Partial FT 'H NMR spectrum o f  nikkomycin X at 200 MHz. (a) In D 20 .  (b) With sodium 
bisulfite added ( 1.0%). Shifts from DSS (internal reference) in ppm.
negative peak at the origin, due to water, the 
peaks o f interest appear. As expected from its 
polarity, the bisulfite addition compound 3 
has a very low RT (3.65 min) and can be 
easily separated from 2 (RT 7.52 min). The 
preparative chemochromatogram corre­
sponds to 50 mg o f mixture and shows base­
line separation between the peaks corre­
sponding to 3 and 2 (Fig. 3b). The reaction of 
N aH S03 with 1 has the four characteristics 
mentioned in the introduction. Reinjection 
o f  purified 1 in this chromatographic system 
showed that the conversion o f 1 to 3 is quan­
titative, since a single peak was observed at 
RT 3.65 min. Furthermore, no trace of 1 was 
observed in isolated 2.
Figure 4a shows the partial 'H NMR spec­
trum o f purified 1 in D20 . When sodium 
bisulfite is added (1.0%), the result repre­
sented in Fig. 4b is obtained. Conversion of 1 
to 3 in the NMR tube is indicated by loss o f  
the aldehyde proton signal at 9.30 ppm (Fig.
4b) and the appearance o f a new singlet at 
5.35 ppm that corresponds to -C//O DSO J.4 
The singlet at 7.70 ppm in Fig. 4a, corre­
sponding to H-5 (1), is strongly shifted up­
held in Fig. 4b (6.75 ppm) due to its proxim­
ity to the sulfonate moiety. These NMR re­
sults show that the aldehyde group in  
nikkomycin X is rapidly and quantitatively 
converted to an addition compound under 
conditions simulating those in the chroma­
tography column.
After reversal of the addition compound 3 
using the procedure described under Mate­
rials and Methods, nikkomycin X was de­
salted on a C |8 reversed-phase column. In 
this manner we were able to recover 29.5 mg
4 The resonances o f aldehyde protons in sodium bi­
sulfite addition compounds fall in the range 4.5-5.0 ppm 
for aliphatic aldehydes listed in (17). For the bisulfite 
addition product o f benzaldehyde, that resonance is at 
5.SI ppm (in DjO) (unpublished results).
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of pure nikkomycin X. This represents a 78% 
yield assuming that 1 is present as the double 
trifluoroacetic acid salt in the mixture ( 1 + 2 )  
as it is in purified 1.
In contrast to the desalting o f nikkomycin 
X which was carried out on a C18 column, a 
different approach was taken to desalt nik­
komycin Z. This change was necessitated by 
our observation that NaH S03 reacts slowly 
with nikkomycin Z under the conditions 
used to concentrate the HPLC fractions prior 
to desalting. We believe that the bisulfite 
adds to the double bond o f the uracil ring. A 
similar reaction of bisulfite with a pyrimidyl 
double bond was previously observed during 
conversion o f polyoxin D to polyoxin L (18). 
Although we could desalt 2 by degassing the 
concentrated solution at low pH, raising the 
pH with NaOH, and injecting onto a re­
versed-phase HPLC column, it proved more 
convenient to desalt using activated carbon. 
The total recovery o f nikkomycin Z was 6.2 
mg, which represents a 67% yield if one takes 
into account that the hydrated free peptide is 
obtained, and assuming a 3H20  • 2TFA form 
in the starting material, as in the case o f nik­
komycin X. Significant losses were taken 
during the desalting step and are probably 
due to irreversible adsorption to the acti­
vated carbon column. No attempt was made 
to optimize this step.
Inhibition o f chitin synthetase was assayed 
for isolated 1 and 2 using a mixed membrane 
fraction from Candida albicans H -3 17 
(19,20). For nikkomycin X an IDj05 value of 
0.1 Mg/ml was obtained and for nikkomycin 
Z the IDso value was 0.24 Mg/ml. Under vir­
tually identical conditions polyoxin D was 4- 
to 10-fold less active (20). The MIC6 foT nik­
komycin X was determined to be ~ 4  pg/ml 
when tested with C. albicans 124. These re­
5 The concentration or compound that inhibited by 
50% the activity o f  chitin synthetase as measured by the 
incorporation of A'-acetylglucosamine into chitin.
6 The lowest concentration of antibiotic that clearly 
inhibits growth.
I ■
suits are comparable to findings reported in 
the literature using other test organisms. Spe­
cifically using chitin synthetase from Co- 
p rim s cinereus nikkomycin was a 2- to 6- 
fold more effective inhibitor than polyoxin D  
(7). Using strain C. albicans 124, McCarthy 
el al. (21) report an MIC o f 25 Mg/ml for a 
mixture o f nikkomycins X and Z (80% pure). 
C. albicans Tii 164 yielded an MIC o f 1 
Mg/ml when tested against nikkomycin X 
(22). Given the known dependence o f MIC 
values on media and laboratory protocol all 
o f these findings are in reasonable agree­
ment.
CONCLUSION
The methods described herein allow the 
rapid and efficient separation o f nikkomycin 
X and nikkomycin Z. In addition to the pre­
parative potential o f the procedure it is obvi­
ous that chemochromatography with a reac­
tive mobile phase is an excellent procedure 
for the analysis of mixtures o f these com­
pounds. The extension o f this approach to 
other isomeric molecules differing in their 
functional groups should add a significant 
tool to the arsenal o f the chromatographer.
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Chapter III. Nikkomycin and polyoxin analogs.
Dipeptide polyoxin analogs.
In 1971 Isono et a l . prepared dipeptide analogs of 
polyoxins and tested their toxicity against some 
phytopathogenic fungi (72, 73). Representative results for 
these and further experiments carried out by other 
investigators (see below) are shown in Table 4. The 
compounds at entries 2 and 3, showed a toxicity comparable 
to that of Polyoxin J (entry 1), indicating that the 
hydroxyl groups in the carbamoyl polyoxamic acid are not 
necessary for activity. The studies of these investigators 
also showed that compounds containing a second amino group 
in the amine terminal residue (entries 9 and 10, Table 4), 
as well as compounds where this residue has the d 
configuration (entries 8 and 12), have very weak or no 
toxicity.
In 1974 Hori et al. took these studies one step 
further and assayed the dipeptide analogues as inhibitors 
of a chitin synthetase preparation from Piricu l a r i a  oryzae 
(74). They assessed the partial binding affinities to 
chitin synthetase of different atomic groups or moieties of 
the polyoxin molecule. Their results complement the 
findings by Isono. The investigators showed that the change
R,-HH
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* * Bet.1 Polyoxin J l-CH(OH)CH(OH)CHjOCONHj CH, H 25 722 ol-CH,CHjCHjOCOSHj ch3 H 12.5 72
3 Cltrullyl L-CHjCHjCHjNHCOHH, CH, H 12.5 726 L-CHjCHjCHjHHC0CH3 CHj H 12.5 725 Glutaalnyl L-CH2CHjCOMH2 ch3 H 50 726 Clutaayl l-CHjCHjCOjH ch3 H >200 73
7 Horvalyl L-CHjCHjCH, CH3 H 25 72
8 o-Horvalyl D-CHjCHjCHj cb3 H >200 73
9 Ornithyl L-CHjCHjCHjNHj CHjOH H 200 7210 Lysyl l-cHjCH3ch2ch,hh2 CH,OH H >200 72
11 Alanyl l-CHj CH* H 50 72
12 D-Alanyl d-CH, CH, H >200 72
13 Glycyl H ch3 H >200 72
16 Phenylalanyl CHjOH H 200 73
15 t-CHjCH2CHjHH00-^^ CHjOH H >200 73
16 L-CHjCHjCHjHHOOC, jH„ CHjOH H >200 73
17 Polyoxin D L-CH(OH)CH(OH)CHjOCOHHj co2h H 0.02 1.8 - <10 77
18 Hoaophenylalanyl H H 0.06 3.8 •f <10 77
19 Horleucyl l-CHjCHjCHjCHj H H 0.17 16 <10 7720 Cltrullyl l-CHjCHjCH2NHCOWH2 H H 0.50 6B <10 77
21 Tyrosyl l-ch2-^^-oh H H 8.00 4.9 22 77
22 Trlptophanyl H H 0.13 1.7 + <10 77
23 l-ch2- © - o^ oh H H 2.00 16 <10 77
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transport of (Met)3 into C. albicans. A 10-fold molar excess of analogue was used. '[Percent 
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of configuration at position a of the amino acyl residue 
from l to d ,  as well as the shift of the amino group 
position from a to 0, reduces considerably the binding to 
the enzyme. Interestingly, they found a high inhibitory 
activity for phenylalanyl polyoxin C, a compound that Isono 
et a l . (73) showed to be non-toxic (Table 4, entry 14). 
These results indicate that this analog does not reach its 
target enzyme within the cytoplasm: it is either unable to
permeate efficiently the cell wall, or is rapidly degraded
(by peptidases) inside the cell.
The authors also demonstrated that the amino group at 
c - 2 ' '  is crucial for binding to the enzyme (74). 
Furthermore, they showed that in order to have effective 
inhibition, the pH of the medium has to be such that the 
amino group at C-2" is protonated (75).
It had been shown (76) that dipeptides antagonize the 
inhibitory action of polyoxins against phytopatogenic 
fungi. In 1983, studies from this laboratory demonstrated 
that polyoxin D greatly affects the morphology of the
zoopathogenic yeast C. albicans and is fungicidal at
millimolar concentrations. It was proposed that transport 
of polyoxin into c.  albicans is mediated by peptide 
permeases (22). In 1984, Mehta et a l . showed this to be 
indeed the case (23).
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Thus, logical evaluation of polyoxin analDgs should 
include not only the usual toxicity studies, but also 
assays of chitin synthesis inhibition and transport into 
the cell. Furthermore, since the antibiotics can be 
degraded by peptidases in the cytoplasm before reaching 
their target enzyme, stability in the presence of cell 
extracts should also be evaluated (70).
Shenbagamurthi et a2. prepared a series of polyoxin L 
analogs specifically designed as anticandidal agents (Table 
4, entries 18 to 23 )(70). These compounds were good chitin 
synthetase inhibitors, but high doses were necessary in 
order to inhibit c. albicans growth. This was shown to be 
due to poor transport and/or degradation to inactive 
products by intracellular enzymes. If polyoxins could be 
chemically modified, in such a way that they would 
penetrate C. albicans, resist enzymatic degradation, and 
inhibit chitin synthetase, efficient killing of this yeast 
would result. Novel dipeptide chitin synthetase inhibitors 
resistant to intracellular degradation were prepared in 
this laboratory (70, 78) (Table 4, entries 27 to 31). The 
resistance to enzymatic hydrolysis was achieved by 
utilizing a D-amino acid (entry 29), or by N-alkylation of 
the terminal amine (entries 27 and 28). Resistance to 
peptidases also resulted from incorporation into the
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polyoxin of an amino acid with a bulky hydrophobic residue 
(entries 30 and 31). An important finding was that although 
the first two strategies resulted in poor chitin synthetase 
inhibitors (entries 27 to 29), the hydrophobic polyoxins 
(entries 30 and 31) were excellent inhibitors of this 
enzyme. Nevertheless, these latter two antibiotics did not 
seem to utilize the peptide transport system to reach the 
cytoplasm and were non-toxic (78) .
Recently, hydrolysis resistant and transportable 
inhibitors were prepared in this laboratory (79)(i.e. entry 
36, Table 4). The MIC values were perhaps higher than one 
would expect, and probably not low enough for clinical 
applications. It should be pointed out that extreme care 
has to be exercised when interpreting the biological 
assays. In particular, the transport competition results 
might very well be reflecting affinity of the inhibitor but 
not translocation into the cytoplasm. It has been shown, 
for instance, that nikkomycin has a high Km for the peptide 
permeases but its Vm is much lower (~5%) than that of 
dimethionine (27). Further limitations of the biological 
assays will be discussed later.
Table 5 lists other dipeptide polyoxin analogs found 
in the literature, with structural modifications such as a 
N-methyl group at the amide (entry 2), or a d configuration
I HO OH Chitin Synthetase
Configuration  Inhibition_______ Hydro-
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9 ch2ch2ch2ch3 H h 2h nh2 H o L L ID5 0 -200uH + 69
T able 5 M odified  d lp e p t id e  p o ly o x in s
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at C-5'(entries 3 and 4). The mentioned compounds were 
intended to be hydrolysis resistant (80). Analogues with a 
p-amino group, or a a-aminooxy group (entries 6 and 8) have 
also been prepared (70, 74). None of these analogues proved 
to be a good chitin synthetase inhibitor.
Trineotide nolvoxin analogs.
Hoping to obtain analogs with greater permeability, 
Isono's group prepared some tripeptidyl polyoxins (Table 6, 
entries 1 to 7) along with the dipeptides mentioned above 
(73). Inclusion of an adamantoyl group in the 6-amino group 
of an amine-terminal ornithine (entry 6) resulted in a 
considerable decrease of activity. The toxicity of the 
other tripeptides toward P. oryzae was not significantly 
higher than that of Polyoxin J (Table 4, entry 1), the best 
drug being Leucyl-Polyoxin L (Table 6, entry 4).
Naider et al . (81) synthesized tripeptidyl polyoxins 
(Table 6, entries 8 to 10), some of which behaved as 
prodrugs. Although none of these compounds were chitin 
synthetase inhibitors, Leu-Polyoxin D and Leu-Nle-UPOC 
(entries 8 and 9) were shown to deliver toxic species 
(Polyoxin D and Nle-UPOC respectively) after hydrolysis 
inside C. albicans. Nle-UPOC was hydrolyzed further, to Nle 

























Gly-Polyoxin L 50 73
Ala-Polyoxin L 12.5 73
( d ) Ala-Polyoxin L 12.5 73
Leu-Polyoxin L 6.25 73







Leu-Polyoxin D >100 0.25 + 11 81
Leu-Nle-UPOC >100 2 + 59 81Nle-UPOC-Leu >100 4 + 7 81
Phe-d2Phe-UPOC 40 >2 - no 69
CH3(CH2)gCO-NH-Phe-Polyoxin D 47.5 1 - no 69
Polyoxin D 0.03 - 10 81
T able 6 T r ip e p tid e  P o ly o x in s
■i*-
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diminished the efficacy of the drug.
Other tripeptidyl polyoxins prepared in this 
laboratory (70) (entries 11 and 12) inhibited chitin 
synthetase to some extent, a fact that was unexpected.
These compounds are the first known tripeptide inhibitors 
of chitin synthetase. They resisted degradation and had low 
toxicity against c. albicans.
New tripeptidyl polyoxins and nikkomycins, designed to 
be degraded by peptidases at specific bonds, will be 
examined in the next section. Dipeptide analogs designed as 
double targeted drugs will also be considered.
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Synthesis and biological evaluation of dipeptidvl and 
tripeptidyl polvoxin and nikkomycin analogs as anticandidal 
prodruas.
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Nine analogs (1-5, 9-12) of the peptidyl nucleoside 
antibiotics nikkomycin and polyoxin were synthesized and 
tested for their biological properties against different 
strains of the pathogenic yeast Candida albicans. The 
tripeptidyl series of analogs (1-5) was designed to behave 
as prodrugs, releasing a toxic moiety upon enzymatic 
hydrolysis inside the cell. The dipeptidyl series (9-12) 
was designed as double-targeted drugs, being themselves 
toxic and releasing a toxic amino acid upon hydrolysis.
All the analogs were prepared by coupling suitably 
protected aminoacid p-nitrophenyl esters to 
1-(5'-amino-5'-deoxy-a-D-allofuranosyluronic acid) uracil 
(UPOC) or the corresponding polyoxins and nikkomycins, with 
subsequent removal of the protecting group. Improved 
coupling yields were observed when DMSO was used as the 
solvent. Products were purified using reversed-phase HPLC 
and, in one case, diastereomeric products (compound 11) 
were resolved using this procedure. One of, the tripeptidyl 
nikkomycins behaved as a prodrug but none of the compounds, 
as measured by in vitro testing, proved more effective than 
nikkomycin as an anticandidal agent.
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INTRODUCTION
Opportunistic infections by Candida albicans are major 
contributors to patient morbidity and mortality in 
immunocompromised hosts1,2. This has become particularly 
significant in recent years with increased use of 
immunosuppressive therapies and with the emergence of 
acquired immunodeficiency syndrome. Since the drugs 
currently in use for the treatment of candidiasis suffer 
from significant clinical limitations, a clear need exists 
for the development of effective anti-candidal drugs.
Polyoxins and nikkomycins are closely related 
families of peptidyl nucleoside antibiotics produced by 
species of Streptomyces. These compounds are toxic to 
phytopathogenic fungi3'5 and, to a lesser degree, to some 
zoopathogenic fungi such as Candida albicans6'7. The 
intracellular target for both families of antibiotics is 
chitin synthetase. This inner membrane enzyme catalyzes the 
synthesis of chitin, a polysaccharide of 
N-acetylglucosamine and an important structural component 
of fungal cell walls. Since no similar macromolecular 
constituent is present in mammalian cells, chitin 
synthetase is an obvious target for an anticandidal agent.
The polyoxins and nikkomycins are potent competitive
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inhibitors of c. albicans chitin synthetase. Values of ID50 
for nikkomycins X or Z fall in the 0.1 - 0.2 ug/mL range8 
when enzyme inhibition is measured in a membrane 
preparation from disrupted c. albicans cells. The MIC 
values, however, are significantly higher (e 10 ug/mL for 
the nikkomycins, see below) when measuring the effect of 
the inhibitors on growth of C. albicans in culture. These 
findings could be the result of the failure of these 
antibiotics to accumulate intracellularly or to their 
metabolism by the yeast. Degradation inside the cell does 
not seem to be the problem, since polyoxins have been shown 
to resist Candida peptidases9, and nikkomycins, on the 
basis of their structural relation to polyoxins, would be 
expected to behave similarly in that respect. In contrast, 
polyoxin and nikkomycin permeation into the cell takes 
place through peptide permeases and this is the step that 
appears to be rate limiting in the case of C. albicans7,10.
We have prepared polyoxins that are very good 
competitors against dileucine uptake in C. albicans, 
indicating high affinity for the dipeptide transport 
system11 yet these compounds were not effective in the 
inhibition of cell growth. It is possible, however, that 
even antibiotics with high affinity for the peptide 
transport system are not efficiently translocated into c. 
albicans. Nikkomycin Z has been shown to have the same Km
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for transport as dimethionine but the Vm was only five 
percent of that of the dipeptide10. Furthermore, 
a-aminolauryl UPOC, a synthetic polyoxin analog recently 
prepared by us11 is an excellent chitin synthetase 
inhibitor, is stable to intracellular degradation and has 
high affinity for the dipeptide transport system. However, 
it fails to kill C. albicans possibly because it is not 
translocated efficiently into the yeast.
Some strains of c.  albicans handle peptides through at 
least two distinct transport systems with different 
selectivities for dipeptides and tripeptides7,10. It is 
possible that the efficacy of the polyoxins and nikkomycins 
might be increased if these dipeptidyl nucleosides could 
also enter C. albicans through the tripeptide transport 
system. In addition even if nikkomycin or polyoxin were 
degraded inside the yeast, killing would still result if at 
least one of the degradation products remained toxic. To 
explore the above strategies, we have prepared a number of 
tripeptidyl nikkomycins and polyoxins using amino acid 
residues expected to improve recognition by the tripeptide 
transport system (Table 7). These tripeptides should not be 
inhibitors of chitin synthetase but should be hydrolyzed to 
toxic dipeptides. Thus they are putative prodrugs. We have 
also synthesized a variety of polyoxin analogs containing a 
known antimetabolite (Table 8, 10-12). These multi-targeted
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drugs have the potential to inhibit chitin synthetase and 
release the toxic amino acids oxalysine12, 
meta-fluorophenylalanine13 and N 3-(4-methoxyfumaroyl)- 
- l- 2 , 3-diaminopropanoic acid (FMDP)14. In this 
communication we report the synthesis of novel polyoxin and 
nikkomycin analogs and the evaluation of their 
intracellular stability, transportability, inhibition of 
chitin synthetase, and anticandidal activity.
CHEMISTRY
1-(5'-amino-5'-deoxy-a-d-allofuranosyluronic acid) 
uracil, which we have previously designated UPOC (uracil 
polyoxin C)), is the carboxyterminus amino acid of the 
synthetic dipeptides 9, 10, 11, 12, and of tripeptides 1 
and 2. It was synthesized from uridine, according to 
Damodaran e t al15. All analogs were prepared by coupling 
suitably protected amino acid p-nitrophenyl esters with 
UPOC or with polyoxins and nikkomycins (compounds 6 to 9) 
and removing the protecting group. Compound 9 has 
previously been synthesized in our laboratory16. In the 
former report, Z-e-(oct)Lys-ONp was coupled to UPOC in 
DMF/H20, in the presence of NMM. The overall yield 
(coupling and deprotection) was only 29%. This was 
attributed to the low solubility of UPOC in DMF. Normally, 
this can be improved by addition of water but in this case
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the amount of water had to be kept low to avoid 
precipitation of Z-(oct)Lys-ONp. Dramatic improvement in 
yield and product purity was attained by systematically 
varying the solvent, base and catalyst (HOBt). Optimal 
conditions found for preparation of 9 were DMSO as solvent, 
DIEA as base, and no catalyst. Indeed, the addition of HOBt 
did not result in any improvement and complicated 
purification of the product. The overall yield of coupling 
and deprotection was 72%, based on UPOC.
Since the solubility properties of the dipeptides were . 
better, DMF/H20 was used as the coupling solvent for 
preparing all tripeptides. We noticed that the yield of the 
coupling reaction varied significantly from batch to batch 
for (oct)Lys-(oct)Lys-UPOC (2.). The decreases in yield were 
consistently accompanied by the appearance of an impurity 
during the coupling reaction. The impurity was detected 
during the monitoring of the reaction by TLC, had an Rf 
slightly higher than the starting unprotected amino acid or 
dipeptide, and was visible under UV light but did not give 
a positive reaction with ninhydrin, indicating that a free 
amine was not present. Small amounts of this impurity were 
isolated during the purification of 2, and NMR analysis 
showed it to be the N-formylated dipeptide. This 
formylation was correlated to the presence of variable 
amounts of formic acid in the starting dipeptide. Formate
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salts can be formed during precipitation of the products of 
catalytic transfer hydrogenation where formic acid is the 
hydrogen donor. NMR analysis showed that 9 exists at least 
partially as a formate salt. This kind of chain terminating 
side reaction has been described for couplings with active 
esters of amino components present as acetate salts, and 
would involve the formation of mixed anhydride 
intermediates17,18. The side reaction was not detected 
during the synthesis of the other tripeptides (1, 3, 4, 5) 
where the starting dipeptides were previously purified by 
HPLC and were present as trifluoroacetates. Since many 
laboratories now routinely use catalytic transfer 
hydrogenation with formic acid as the donor for 
deprotection of peptides, it is advisable to exchange the 
formate salt prior to chain extension.
Polyoxin B was purified according to 19, and its 
structure confirmed by XH and 13C nmr spectroscopy. The 
proton NMR of Leucyl-polyoxin B (5) in DMSO showed the 
expected resonances, but the H-l' doublet as well as one of 
the CONH doublets were split (see experimental section). 
This was attributed to the coexistence of two stable 
conformers of roughly the same populations in DMSO. This 
phenomenon was not observed in any of the other tripeptides 
(1 to 4), although the spectrum of one of the dipeptides 
(m-F-Phe-UPOC, peak II) in DMSO-d6 showed a split CONH
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doublet, a split H-6 doublet, a broad NH-3 resonance and a 
complex H-l', H-5' region. For this latter compound the 
spectrum was not simplified even when run at 55°C. However 
when the nmr sample was frozen, thawed, and the spectrum 
run immediately at 25°C the split peaks collapsed into the 
expected pattern (analogous to that observed for peak I, 
see experimental section).
L-4-oxalysine12 and (d,l)- m e t a - f luorophenylalanine 
were protected with benzoyloxycarbonyl groups (Z) by 
standard procedures20. Boc-FMDP was prepared according to 
14. All three protected amino acids were activated as 
p-nitrophenyl esters, coupled to UPOC and deprotected, to 
yield dipeptides 10, 11 and 12. The two epimers of 11 were 
separated by HPLC, and the peak with faster mobility (peak
I) identified as the l , l  diastereomer on the basis of its 
hydrolysis by C. albicans peptidases and inhibition of 
chitin synthetase. In contrast the slow moving epimer (peak
II) was resistant to hydrolysis under the same conditions 
and did not inhibit chitin synthetase (see Biological 
Results).
BIOLOGICAL RESULTS AND DISCUSSION
Inhibition of Chitin Synthetase
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The synthetic polyoxins and nikkomycins fall into two 
distinct categories. As expected, none of the tripeptidyl 
derivatives (1-5) were efficient inhibitors of chitin 
synthetase (Table 7). The best inhibitor (5) was 
approximately 25 times less active than the parent compound 
(8, see Table 8). In comparison the nikkomycin derivatives 
(3, 4) were^a minimum of 270 fold less active as compared 
to the parent compounds 6 and 7, respectively (Table 7 and 
Table 8). Of the dipeptidyl polyoxins (£, 10, 11, 12) only 
9 and 11 ( l , l diastereomer) were reasonably good inhibitors 
(Table 8). In the case of the oxalysine containing 
polyoxin (10) the poor inhibition may be attributed to the 
high hydrophilicity of the Oly residue. In previous 
investigations, semisynthetic polyoxins with charged or 
polar side chains in the amine terminal residue were poor 
inhibitors of chitin synthetase from C. albicans11,16 and 
phytopathogenic fungi21. Based on their poor inhibition of 
chitin synthetase, the tripeptidyl antibiotics are expected 
to be active against C. albicans only if they are 
efficiently transported into this yeast and hydrolyzed to 
an active drug. Of the four synthetic dipeptidyl 
derivatives, only 9 and 11 would be expected to kill the 
yeast by inhibition of cell wall biosynthesis.
Competition for peptide transport
i
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The tripeptidyl nucleoside antibiotics synthesized in 
this study (Table 7) were designed to be transported by 
permeases able to handle tripeptides7. Once inside the 
cell, they were expected to be hydrolyzed by cytoplasmic 
peptidases, releasing dipeptide chitin synthetase 
inhibitors. As shown in Table 7, with the exception of 2 
none of the tripeptides competed with the uptake of (Leu)2* 
It was unexpected that tripeptide 2 would compete well with 
dipeptide uptake. Furthermore, compound 2 competed with 
tripeptide transport as well. However, all other 
tripeptidyl compounds (1, 2, 4, and 5) competed poorly with 
the tripeptide substrate (Met)3. These results were 
surprising, because based on the structural specificity of 
the tripeptide transport system in c.  a l b i c a n s 7 the 
additional leucyl residue at the amine terminus was 
predicted to result in increased affinity.
The nikkomycins, 6 and 7, have high affinity for the 
dipeptide transport system (Table 8 ), while polyoxin B,
(8 ), does not compete with the uptake of either (Leu) 2 nor 
(Met)3. Among the synthetic dipeptides, only 9 and 10 were 
reasonably well recognized by the system transporting 
(Leu) 2 (Table 8 ). In the case of 10 this is somewhat 
unexpected given its high hydrophilicity and the low 
affinity of the oligopeptide transport system of c. 
albicans for lysine containing peptides7. Perhaps more
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surprising is the lack of transport inhibition shown by 1 1  
which is structurally very close to the nikkomycins, 
although much more hydrophobic. Previous investigations had 
indicated that hydrophobic peptides are better inhibitors 
of peptide transport in C. albicans than are hydrophilic 
peptides 7.
Hvdrolvsis bv cell extracts
The tripeptidyl polyoxins are ineffective in vitro 
inhibitors but may be activated by intracellular enzymes to 
generate polyoxins and nikkomycins which are effective 
chitin synthetase inhibitors (Tables 7 and 8 ). We found 
that cell extracts from C. albicans H-317 degraded 3, 4 and 
5 to leucine and the corresponding polyoxin and 
nikkomycins. Degradation of 3. and 4 was faster than that 
seen for norleucy1-uracil polyoxin C (Nle-UPOC) 9 whereas 
degradation of 5 was somewhat slower. Under the conditions 
used for this assay, Nle-UPOC was completely hydrolyzed 
after a 1 hr incubation with cell extract, 3 and 4 after 
0.5 hr, and 5 after approximately 3 hr. 1 and 2 were not 
degraded at all. These results, as well as the resistance 
to hydrolysis by 9 and other analogs1 6 , 11 suggest that the 
very hydrophobic and bulky residue in the second amino acid 
of 1 and 2 stabilizes both peptide bonds toward peptidase 
degradation by Candida cell extract. The only synthetic
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dipeptide which was readily hydrolyzed by the cell extract 
was the l,L-diastereomer of 11 (peak I) (see Table 8 ).
Both amino acid components were formed as products, as seen 
by TLC. Peak II was resistant to hydrolysis, indicating 
that it is the D,L diastereomer. The hydrolysis of the 
dipeptide 12 proceeded very slowly, half of the peptide 
being consumed in about 3 hr as monitored by HPLC.
Inhibition of growth of C. albicans
We studied the effect of peptides (1-12) and the toxic 
amino acids on the growth of three strains of C. albicans 
(Tables 7, 8 and 9). Two of the strains were wild type 
(H-317 and 124) whereas strain 124N5 is resistant to 
nikkomycin. It was necessary to determine the toxicity of 
the component amino acids prior to evaluation of 1 0 -1 2 . 
m-F-Phe has been found to be inactive against c. albicans 
(strains B311 and 759) unless it is transported inside the 
cell by peptide carriers13,22. Similar results were 
observed against the strains examined in this investigation 
(Table 9). Oxalysine shows some toxicity against all the 
strains tested (Table 9). In contrast to the reported lack 
of toxicity of FMDP when tested against c. albicans AMB 25 
(MIC 2: 200 ug/mL)23, this amino acid showed high toxicity 
toward the three strains tested here causing growth 
inhibition at 7.8 ug/mL (Table 9).
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The dipeptide 12 showed low toxicity (Table 8 ), a fact 
that can be explained in terms of its failure to inhibit 
chitin synthetase and its low transportability into the 
cell. On the other hand, the low toxicity of dipeptide 10, 
a poor chitin synthetase inhibitor which has a much higher 
affinity for the (Leu) 2 transport system, can be explained 
in terms of its resistance to hydrolysis to toxic Oly if it 
reaches the cytoplasm. The non-toxicity of 11 despite its 
being a good chitin synthetase inhibitor and a good 
substrate for peptidases, can be explained by its low 
transportability into the cytoplasm.
None of the tripeptidyl polyoxins were effective 
anticandidal agents (Table 7). Leu-nikkomycin X which was 
the most potent synthetic analog had an MIC=83 ug/mL 
against C. albicans 124. This MIC is lower than that found 
for the dipeptide 9 despite the fact that the dipeptide is 
a 60-fold more efficient inhibitor of chitin synthetase. 
Thus it appears that 3 behaves as a prodrug. It is 
transported into the pathogen and hydrolyzed to the toxic 
nikkomycin X inside the cell. Its low effectiveness is 
explained by its low affinity for both the di- and 
oligopeptide transport systems. The low toxicity of 1 and 2 
is not surprising because neither of these compounds is 
hydrolyzed by cell extract peptidases and the intact
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tripeptides are poor inhibitors of chitin synthetase. In 
comparison to 3, compound 5 is hydrolyzed at a slower rate 
inside the cell (see above) and releases polyoxin B, which 
is not as potent a chitin synthetase inhibitor as 
nikkomycin X (Table 8 ). Those differences explain the 
limited effectiveness of 5 against the yeast.
The difference in toxicities of 3 and 4 is difficult 
to explain, since their rate of transport, hydrolysis, and 
inhibiting power of the released moiety is very similar.
One possible explanation is that although their extent of 
affinity for the oligopeptide transport system is almost 
the same, Leu-nikkomycin Z is not translocated to a 
significant extent to an intracellular site. Supporting 
this hypothesis are the data of Yadan et al.10 who showed 
that in C. albicans nikkomycin and dimethionine had similar 
Km values for the dipeptide transport system (4 uM and 6 
uM, respectively) whereas their respective Vm values were 
0.15 pmoles min-1 and 3.5 pmoles min-1.
Recent findings2 4 - 2 6 indicate that two chitin 
synthetase activities are present in Saccharomyces 
cerevisiae. Chitin synthetase 1 is the major in vitro 
activity measurable but is not essential for cell growth 
and appears to be a repair or auxiliary enzyme. Chitin 
synthetase 2 of S. cerevisiae is essential for chitin
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synthesis and septum formation. If multiple chitin 
synthetases exist in C. albicans as well, then it is 
possible that the in vitro activity we measure does not 
accurately reflect in vivo chitin synthesis of the cell.
In this case, the correlation between growth inhibition and 
enzyme activity measured may not be valid. Further studies 
must be carried out to determine the number of isozymes of 
chitin synthetase present in C. albicans.
CONCLUSION
This study reports the successful synthesis of novel 
dipeptides and tripeptides which are analogs of polyoxins 
and nikkomycins. Dipeptides containing Oly or FMDP were 
resistant to Candidal peptidases and were consequently 
ineffective drugs. A polyoxin analog containing m-F-Phe 
was not recognized by the peptide transport system.
One tripeptidyl nikkomycin (3) was hydrolyzed to an 
active component after entering the yeast and therefore 
appears to behave as a prodrug. The results show that the 
structural specificity for peptide transport in c. albicans 
may be much more complex than previously believed. It is 
clear that additional knowledge of those molecular 
interactions which are involved in the actual translocation 
of a peptide into the yeast must precede the design of
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chitin synthetase inhibitors which will efficiently kill 
this pathogen.
EXPERIMENTAL SECTION
High-performance liquid chromatography (HPLC, 
analytical, Semipreparative) was carried out on a Waters 
chromatograph (Waters Associates, Milford, MA) equipped 
with two Model 510 solvent delivery units, a U 6K injector 
and a Model 481 variable wavelength UV detector, a Model 
680 automated gradient controller, and a Model 730 data 
module. Analytical separations were carried out on a Waters 
micro-Bondapak C18 reversed-phase column (30 cm x 3.9 mm, 
particle size 10 um) or an Aquapore spheri-5 RP18 column 
(22 cm x 4.6 mm). The mobile phase was MeOH-H20-TFA at a 
flow rate of 1.4 mL/min. The absorbance of the column 
eluants was recorded at 254 nm for all polyoxins. For 
purification of final products two Waters C18 
semipreparative columns (30 cm x 7.8 mm and 15 cm x 19 mm) 
or an Aquapore RP-18 (25 cm x 10 mm) were used. TLC 
analysis was carried out on silica gel 60 F 254 plates, 0.25 
mm (Merck, Darmstadt).
The NMR spectra were recorded on a Bruker WP-200SY 
instrument, and the chemical shift values are reported in 
ppm relative to internal tetramethylsilane. Optical
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rotations were determined on a Perkin-Elmer model 141 
polarimeter. For elemental analyses, freeze-dried samples 
were further dried in vacuum over P 205 at 65°C for 48 
hours. Elemental analyses were performed by Galbraith 
laboratories, Knoxville, Tennessee. Nikkomycin X was 
purified by chemochromatography8 from a crude obtained from 
Bayer Pflanzenschutz Leverkusen. Nikkomycin Z (Calbiochem, 
San Diego, CA) was purified before use by HPLC (solvent,
TFA 0.10%; flow rate, 4.50 mL/min; 19 cm x 150 mm column; 2 
mg shots). Polyoxin B was obtained from an agricultural 
fungicide preparation supplied by Kaken Chemical 
(Honkomagome, Tokyo, Japan) as described in 19, where it is 
referred to as peak I. UPOC (uracil polyoxin C) was 
prepared according to Damodaran e t al.15, and obtained 
mainly as a zwitterion. N-a-benzyloxy-carbonyl-N-e- 
-octanoyl-lysine-p-nitrophenyl ester was prepared as 
described in 16. L-4-0xalysine was obtained as a gift from 
Dr. Hong-Long Zhang, Shanghai Institute of Materia Medica, 
Chinese Academy of Science, Shanghai.
N 2-(tert-Butoxycarbonyl)-N3-(4-methoxyfumaroyl)-l-2,3- 
-diaminopropanoic acid was prepared according to reference 
1 4 .  ( d , l ) -meta-Fluoro-phenylalanine was purchased from 
Chemical Dynamics Corporation (South Plainfield, New 
Jersey).
Polyoxin B (8 ^
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Polyoxin B was purified according to 19 and was HPLC 
homogeneous. Its structure was confirmed by XH and 13C nmr. 
The assigned proton resonances at 200 MHz in DMSO-d6 were:
6 H 4.7 (1H, dd, H-5'), 5.3-5.7 (m, OH), 5.81 (1H, d, J= 6  
HZ, H-l'), 6.53 (2H, broad s, C0NH2 ), 7.39 (1H, s, H-6 ), 
8.0 (3H, broad, NH3+), 9.0 (1H, d, J=8.2 Hz, CONH), 11.48 
(1H, broad s, NH-3). The presence of a H on the 5 position 
is ruled out because H - 6 appears as a singlet at 7.39 ppm.
A CH3 group on this position is also ruled out because 
there is no resonance near 2 ppm corresponding to 5-CH3. A 
carboxyl group on position 5 has also been ruled out 19 on 
the basis of the UV spectrum. The group on the 5 position 
is CH20H, as shown by the 50 MHz 13C proton decoupled 
spectrum. This resonance appears at 57.0 ppm (in water,
C 6D 6 external reference 8=128.0) and is assigned by 
comparison to 5-hydroxymethyl uridine as a model compound 
(59 ppm in H 20, DSS internal reference) and by the 
splitting to a triplet in the off-resonance proton 
decoupled spectrum. Polyoxin G, which also has an 
hydroxymethyl group in position 5 but differs from polyoxin 
B in that the OH group in position 3 • '  is replaced by an H 
atom, was ruled out on the basis of the 1 3C-1H splitting 
patterns under off-resonance proton decoupling conditions. 
The other resonances were: 6 55.2, 56.8 (a-CH), 69.1, 70.2, 
70.4 (CH, ribose and polyoxamic acid side chain), 73.0 (CH,
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ribose), 83.3 (CH, ribose), 91.0 (CH, rlbose), 65.8 
(CH2-5"), 114.4 (C-5), 140.4 (C-6 ) , 152.0 (C-2) , and 
159.5, 165.3, 168.3, and 172.2 (C~4, CONH, OCONH , and 
CO2H, unassigned).
N-€-(OctanovH-lvsvl-(uracil polyoxin C^ ( (octlLvs-UPOCl 
X91
Z-e-(C7H 1 5CO)-Lys-ONp4 (116 mg, 0.22 mmol) and UPOC 
(60 mg, 0.2 mmol) were suspended in DMSO (2 mL). 
Diisopropylethyl amine was added (35 uL, 0.2 mmol) (pH a 7) 
and the mixture stirred at room temperature for 20 hr. (The 
solution cleared up after a few hours). After acidification 
with acetic acid (0.1 mL), the solvents were evaporated in 
vacuo to dryness, the residue suspended in 1 % acetic acid, 
triturated with a spatula, filtered, washed with water and 
dried under vacuum. The solid was resuspended in ether, 
triturated and filtered. Yield 0.108 g (80%). The product, 
Z-€-(C7Hi5CO)-Lys-UPOC was homogeneous on silica thin 
layers using n-BuOH/AcOH/H20 (4:1:2, Rf = 0.59) as eluant, 
and was subjected to transfer hydrogenation using Pd black 
(s30 mg) and 90% formic acid (0.3 mL) in methanol (3 mL). 
The initial suspension clears with time and after 3 hr the 
catalyst was removed by filtration through celite, the 
filtrate evaporated to dryness, and the residue suspended 
in ether, triturated and filtered. Yield 78 mg (72%).
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(Oct)Lys-UPOC was 97% pure as judged by HPLC, and its 
mobility identical to a standard16. Rf = 0.45 
(1-butanol:acetic acid:water, 4:1:2).
N-€-fOctanovl)-lvsvl-N-e-foctanoyl)-lvsvl-UPOC (2)
9, (40 mg, 74 umol) from the previous step, and 
Z-e-(C7H 1 5CO)-Lys-ONp (46.8 mg, 89 umol) were dissolved in 
DMF (0.7 mL). N-methylmorpholine (8.15 uL, 74 umol) was 
added and the mixture stirred at room temperature for 15 
hr. After acidification with acetic acid (0.1 mL), the 
solvents were evaporated in vacuo to dryness. The residue 
was treated with ether, filtered, washed with 4% citric 
acid, water, and dried under vacuum. The product was 
subjected to transfer hydrogenation as described for 9 for
1.5 hr. The catalyst was removed by filtration through 
celite, the filtrate evaporated to dryness, and the residue 
suspended in ether and filtered. 36.2 mg of crude 
(oct)Lys-(oct)Lys-UPOC was obtained, 24 mg of which were 
purified by reversed-phase HPLC using a 250 x 10 mm 
semiprep Aquapore RP-18 column with 0.1% TFA/MeOH 47:53 as 
eluant. 13.9 mg of pure 2 was obtained after concentration, 
suspension in ether and filtration. Yield = 31%, based on 
9. Rf = 0.57 (1-butanol:acetic acid:water, 4:1:2). [o(]d25= 
+8 . 8 (c=0.2, DMF). NMR. 5 HDMS0_d6 0.85 (6H, t, J=6.2 Hz, 
-CH3 ), 1.1-1.8 (32H, m, -CH2-), 2.03 (4H, m,a-CH2 of
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octanoyl), 3.00 (4H, m, €-CH2 of Lys), 3.76, 4.0-4.2 (4H, 
m, H-2', 3', 4#, a-CH, unassigned), 4.35 (1H, m, a-CH),
4.50 (1H, m, a-CH), 5.26 (1H, broad, OH), 5.44 (1H, broad, 
OH) 5.68 (1H, d, J=8.1 Hz, H-5), 5.79 (1H, d, J=6.4 Hz,
H-l# ), 7.54 (1H, d, J=8 .1 Hz, H-6 ), 7.79 (2H, t, 5.8 Hz, 
e-NH of Lys), 7.8 -8 .5 (4H, unresolved, two broad peaks at
8.05 and 8.44 ppm when run at 400 MHz, NH3+ and CONH 
respectively), 8.54 (1H, d, J=8.3 Hz, CONH), 11.38 (1H, 
broad s, NH-3). Elemental Analysis. Found: C, 51.47; H, 
7.33; N, 10.70%. Calculated for CasHgsOnNy • CF3C02H • H 20 
: C, 51,77; H, 7.39; N, 10.56%.
N-g-Formvl-N-e-octanovl-lvsvl-UPOC
Small amounts (1 mg) of this formylated dipeptide were 
isolated as an impurity during the HPLC purification of 
tripeptide 2. R f=0.47 (1-butanol:acetic acid:water, 4:1:2). 
NMR. 6 H D M S ° - d 6 0.86 (3H, t, J=6.1 Hz, CH3), 1.15-1.74
(16H, m,-CH2-), 2.02 (2H, t, J=7.3 Hz, a-CH2 of octanoyl),
2.99 (2H, m, e-CH2 of Lys), 3.95-4.15 (3H, m, H-2', 3',
4'), 4.43 (1H, m, a-CH), 4.56 (1H, m, a-CH), 5.28 (1H, 
broad, OH), 5.44 (1H, broad, OH), 5.64 (1H, d, J=8.3 Hz, 
H-5), 5.79 (1H, d, J=6.4 Hz, H-l'), 7.45 (1H, d, J=8.3 Hz,
H-6 ), 7.75 (2H, broad t, e-NH of Lys), 8.03 (1H, s, CH of
formyl), 8.30 (1H, d, J=8 . 8  Hz, CONH), 8.41 (1H, broad, 
CONH), 11.37 (1H, s, NH-3). FAB mass spectrometry indicated
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a molecular ion [M + H +] at 570.2 daltons. Calculated MW: 
569.6 daltons.
Leucvl-N-(octanovl)-1vsvl-UPOC (1)
The procedure was similar to the preparation of 2, and 
was carried out using Z-Leu-ONp (51 mg, 132 umol) and 9 
(72.1 mg, 110 umol) in 1 mL of DMF. 9 had been previously 
purified, according to 16, and was a TFA salt. The coupling 
time was 42 hr and 50 mg of Z-Leu-(oct)Lys-UPOC (Yield = 
58%) was obtained. It was homogeneous on silica thin 
layers, with n-BuOH/AcOH/H20 (4:1:2, Rf=0.67) as eluant.
The deprotection took 1.5 hr, and 32.5 mg of the tripeptide 
1 was obtained (overall yield = 42%) which was homogeneous 
on silica thin layers, with the same eluant (Rf=0.54) and 
did not need further purification. Reversed-phase HPLC 
analysis (spheri-5 RP-18 column, eluant 0.1% TFA/MeOH 
45:55) showed higher than 99% purity. [a] D 25 = +8.9 
(c=0.09, DMF). NMR. 8HDMSO"d6 0.86 (9H, m, -CH3), 1.15-
1.75 (19H, m, -CH2- and CH), 2.02 (2H, t, J=7.2 Hz, a-CH2 
of octanoyl), 2.98 (2H, m, e-CH of Lys), 3.67, 4.0-4.4 (6H, 
m, H-2', 3', 4', 3 a-CH), 5.26 (1H, d, J=4.4 Hz, OH), 5.60 
(1H, d, J=8 .1 HZ, H-5), 5.75 (1H, d, J=6 . 8 Hz, H-l'), 7.67 
(1H, d, J=8 .1 Hz, H-6 ), 7.82 (1H, t, J=5.1 Hz, e-NH of 
Lys), 7.95 (1H, broad d, J=5.9 Hz, CONH), 8.49 (1H, d,
J=7.3 Hz, CONH). Elemental Analysis. Found: C, 51.63; H,
70
7.50; N, 11.62%. Calculated for C 3 oH5oOioN6 . 2.5 H 20 : C, 
51.49; H, 7.92; N, 12.01% .
Leucvl-nikkomvcin Z (4̂
Nikkomycin Z (double TFA salt) (38 mg, 50 umol) and 
Z-Leu-ONp (23.2 mg, 60 umol) were dissolved in a mixture of 
DMF (0.5 mL) and H 20 (0.15 mL). NMM (17 mL, 150 umol) was 
added and the mixture allowed to react, with stirring, at 
room temperature, for 24 hr. After acidification with 
acetic acid (50 uL), the solvents were evaporated in vacuo, 
the residue treated with ether, filtered and subjected to 
transfer hydrogenation for 2 hr as described above. After 
filtration through celite, washing the filter with water, 
evaporation and precipitation with ether, 35.4 mg of crude 
material was obtained, which was purified by HPLC on a 
semiprep Aquapore RP-18 column with 0.1% TFA/MeOH 95:5 as 
eluant. Homogeneous 5 (26.1 mg) was obtained. (Yield =
45%). [a] D 25 = +17.0 (c=0.1, AcOH). Rf = 0.27 (1-butanol: 
acetic acidswater, 4:1:2). NMR. sH D M S 0 " d 6 0.66 (3H, d,
J=6 .4 HZ, CH3-3"), 0.89 (6H, m, CH3 of Leu) , 1.45-1.70 
(3H, m, p-CH2 and T“CH of Leu), 3.8-4.2, 4.5-4.7 (H-27, 3', 
47, 5', 2", a-CH of Leu, unassigned), 4.75 (1H, broad, 
H-4"), 5.70 (1H, d, J=7.8 Hz, H-5) 5.81 (1H, d, J=5.4 Hz, 
H-l7) , 7.2-7.4 (2H, m, H-3'", 4777), 7.49 (1H, d, J=7.8 
Hz, H-6 ), 8 .0-8.2 (4H, broad, NH3+ and H-6 '77), 8.43 (1H,
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d, J=8 .3 Hz, CONH), 8.63 (1H, d, J=7.8 Hz, CONH), 9.95 (1H, 
broad, ArOH), 11.42 (1H, s, NH-3). Elemental Analysis. 
Found: C, 34.70; H, 4.23; N, 7.45%. Calculated for
C 2«H3 6 0 h N 6 • 3.5 CF3CO2H • 8 H 20 : C, 34.41; H, 4.86; N, 
7.30%.
Leucvl-nikkomycin X (3)
Nikkomycin X (double TFA salt) (40 mg, 53 umol) was 
processed as described above for nikkomycin Z, with the 
exception that 1.2 equivalents of Boc-Leu-ONp were used as 
the coupling reagent. Coupling time was 30 hr. Deprotection 
was accomplished with TFA/CH2C12 (50:50) in 0.5 hr. The 
solvents were evaporated under vacuo, and the residue 
precipitated with ether and filtered. Crude product (36.2 
mg) was purified by HPLC using a 15 cm x 19 mm C-18 column, 
with TFA 0.05% / MeOH 96:4 as the eluant. Homogeneous 3 
(20.5 mg) was obtained after concentration and 
freeze-drying (Overall yield = 39%). [a] D 25 = +18.0 (c=0.1, 
AcOH). Rf = 0.29 (1-butanol:acetic acid:water, 4:1:2). NMR. 
5HDMS°-d6 0>66 J=6>6 HZf CH -3"), 0.89 (6H, m,
CH3 of Leu), 1.45-1.70 (3H, m, p-CH2 and t“CH of Leu), 3.75 
- 4.65 (H-2', 3', 4', 5', 2 ", a-CH of Leu, unassigned),
4.76 (1H, broad, H-4"), 5.47 (1H, d, J=4.3 Hz, H-l'),
7.2-7.4 (2H, m, H-3"-4"), 7.72 (1H, S, H-5), 8 .0-8.2 (4H, 
broad m, NH3+ and H-6 "), 8.46 (1H, d, J=9.0 Hz, CONH),
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8.64 (1H, d, J=9.5 Hz, CONH), 9.24 (1H, S, CHO), 11.2 (1H, 
s, NH-3). Elemental Analysis. Found: C, 38.96; H, 4.57; N,
8.84%. Calculated for C 26H 3 60iiN6 • 3 CF3C02H • 2.5 H 20 :
C, 38.60; H, 4.45; N, 8.44%.
Leucvl-oolvoxin B (5)
Polyoxin B (TFA salt) (62 mg, 0.1 mmol) and Z-Leu-ONp 
(46 mg, 0.12 mmol) were dissolved in a mixture of DMF (1 
mL) and H 20 (0.3 mL). NMM (22.4 uL, 0.2 mmol) was added and 
the mixture stirred at room temperature for 44 hr. After 
acidification with acetic acid (0.1 mL), the solvents were 
evaporated in vacuo, and the residue treated with ether and 
filtered. 40 mg of Z-Leu-polyoxin B (yield = 53%) was 
obtained. Rf = 0.72 on silica thin layers with 
n-BuOH/AcOH/H20 (1:1:1) as the eluant.
This product was subjected to transfer hydrogenation 
in methanol (2 mL) with palladium black (s30 mg) and 90% 
formic acid (0.2 mL) for 24 hr. The crude product was 
purified on a C 18 reversed-phase column using 0.05%
TFA/MeOH (100:1) as eluant. The fractions containing pure 4 
were pooled, evaporated under vacuum and freeze-dried. 7.2 
mg of material, showing more than 92% purity by HPLC 
analysis, was obtained. Other fractions containing 4 were 
concentrated under vacuum and reinjected onto the 19 cm x
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150 mm C-18 column with 0.05% TFA/MeOH (10012) as the 
eluant. 4.5 mg of 100% HPLC homogenous material was 
obtained after concentration and freeze-drying. (Overall 
yield: 11%). [a] D 26 = +14.0 (c=0.1, AcOH). Rf = 0.22 
(1-butanol:acetic acidrwater, 4:1:2). NMR. sHDMS0"d6 0.89 
(6H, d, J=5.4 Hz, CH3 of Leu), 1.45-1.80 (3H, m, p-CH2 and 
T-CH of Leu), 3.6-4.3, 4.4-4.7 (m, unresolved, H-2', 3',
4', 3", 4 ", CH2“5", CH20H, 3 a-CH), 5.81 and 5.82 (1H, 
split d, J=5.9 Hz, H-l'), 6 .4-6.8 (2H, broad, OCONH2), 7.42 
(1H, s, H-6 ), 8 .0-8.2 (3H, m, NH3+), 8.65 and 8.90 (1H, 
split d, J=8.1 Hz, CONH), 8.74 (1H, d, J=7.8 Hz, CONH),
11.50 (1H, s, NH-3), 13.15 (1H, broad s, C0 2H). Elemental 
Analysis. Found: C, 34.60; H, 3.90; N, 8.46%. Calculated
for C 23H 3 60 14N 6 • 3.5 CF3C02H • H 20 : C, 34.73; H, 4.03; N, 
8.10%.
L-4-Oxalvsvl-UPOC. (Olv-UPOCl. (10)
N 2,N6-di-Benzoyloxycarbonyl-L-4-oxalysine was prepared 
by standard procedures20 from L-4-oxalysine, and 
crystallized from ether. (Rf = 0.52, CH2Cl2/MeOH 10:3.2).
It was converted into the p-nitrophenyl ester by coupling 
to p-nitrophenol with dicyclohexylcarbodiimide in THF and 
crystallizing from isopropanol. Yield: 50%. This product 
was homogeneous on silica thin layers (Rf=0.76, CH2Cl2/MeOH 
95:5). NMR. 8 H C D C 1 3 3.32-3.47 (2H, m, €-CH2), 3.53-3.66
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(2H, m, 8-CH2), 3.84 (1H, dd, J=9.3 Hz, 3.0 Hz, p-CH), 4.08 
(1H, dd, J=9.3, 3.0 Hz, p-CH), 4.77 (1H, m, a-CH), 4.99 
(1H, broad, €-NH), 5.08 (2H, s, benzylic CH2), 5.15 (2H, s, 
benzylic CH2), 5.79 (1H, d, J=7.2 Hz, a-NH), 7.2-7.4 (1 2H, 
m, phenyl), 8.17 (2H, d, J=8.5 Hz, meta of p-NO2-phenyl). 
(a,e-dibenzyloxycarbonyl)-Oly-ONp (85.7 mg, 160 umol) was 
coupled to UPOC.HC1 (46.9 mg, 145 umol) in DMSO (1.45 mL) 
in the presence of DIEA (50.5 uL, 290 umol) at room 
temperature for 25 hr. The reaction mixture was acidified 
with acetic acid (300 uL) and the solvents evaporated in 
vacuo to dryness. The residue was suspended and triturated 
in AcOH 1%, filtered, suspended and triturated in ether, 
and filtered. This diprotected dipeptide was homogeneous on 
silica gel thin layers (Rf=0.29, 1-butanol:acetic acid: 
water, 4:1:2). It was suspended in MeOH (4 mL) and 
subjected to transfer hydrogenation with palladium black 
(«40 mg) and 90% formic acid (0.4 mL) with stirring at room 
temperature overnight. The catalyst was removed by 
filtration through Celite, the filtrate evaporated under 
vacuo to dryness, and the residue suspended in Et20, 
triturated and filtered. Yield 33.4 mg (45%). Rf=0.09 
(1-butanol:acetic acid:water, 4:1:2). Due to the extremely 
high hydrophilicity of this material, no satisfactory 
reversed-phase HPLC analysis could be performed, but its 
homogeneity was supported by TLC, NMR and elemental 
analysis. [a] D 25 = +25.8 (c=0.12, H 20). NMR. 8 H D M S ° - d 6
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2.95 (2H, m, €-CH2), 3.57 (in, 
H-5', a-CH, H-2'-3'-4'), 5.62 
(1H, d, J=6 . 6 Hz, H-l'), 7.76 
(1H, d, J=7.7 Hz, CONH), 8.24 
Elemental analysis. Found: C 
Calculated for C 1 5H 2 3O 9N 5 
5.54; N, 13.28%.
p-CH2, t-CH2), 4.02-4.35 (m, 
(1H, d, J=8 .0 HZ, H-5), 5.78 
(1H, d, J=8 .0 Hz, H-6 ), 8.01 
(2H, s, formate counterion). 
, 38.64; H, 5.92; N, 13.25%.
. 2 CH 20 2 • H 20 : C, 38.71; H,
meta-Fluorophenvlalanvl-UPOC f11)
Benzoyloxycarbonyl-(d,l)-m-fluorophenylalanine was 
prepared by standard procedures20 from 
(d,l)-m-fluorophenylalanine and crystallized from ether. 
Yield, 81%, (Rf=0.56, n-butanol:acetic acid:water, 4:1:2). 
It was converted into the p-nitrophenyl ester by coupling 
to p-nitrophenol with DCC in THF and crystallizing from 
isopropanol. Yield 52%. NMR. 8 H D M S O _ d 6 3.0-3.3 (2H, m, 
p-CH2), 4.61 (1H, m, a-CH), 5.05 (2H, s, benzylic CH2),
7.03-7.43 (11H, m, phenyl), 8.14 (1H, d, J=7.7 Hz, OCONH), 
8.32 (2H, d, J=9.0 Hz, raeta of p-NO2-phenyl).
(d ,l)-Z-m-fluorophenylalanine-p-nitrophenylester was 
coupled to UPOC.HC1 as described for compound 10. The 
protected dipeptide was homogeneous on silica gel thin 
layers (Rf=0.46, 1-butanol:acetic acid:water, 4:1:2). It 
was subjected to transfer hydrogenation as described above. 
Yield 59 mg (55%). The two diastereomers were observed on 
TLC (Rf=0.17 and 0.21, 1-butanol: acetic acid: water,
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4:1:2) and were separated by semipreparative HPLC. 37 mg of 
the product were injected onto the Waters Ci 8 column and 
eluted with 0.025% TFA in H 20:acetonitrile, linear gradient 
of 5% to 10% acetonitrile in 1 hr. In this way, 18.5 mg of 
one diastereomer (peak I) and 11.5 mg of the other (peak 
II) were obtained.
Peak I: [ oO d 2 5  = +44.1 (c=0.17, H 20). NMR. 6 H D M S O " d 6
2.8-3.2 (m, P-CH ), 3.99 (1H, t, J=3.8 Hz, H-4'), 4.0-4.3 
(3H, m, a-CH, H-2', H-3'), 4.62 (1H, m, H-5'), 5.35 (broad, 
OH), 5.51 (1H, d, J=5.4 Hz, OH), 5.67 (1H, d, J=8.1 Hz, 
H-5), 5.80 (1H, d, H=5.8 Hz, H-l'), 7.02-7.45 (4H, m, 
phenyl), 7.53 (1H, d, J=8.1 Hz, H-6 ), 8.2 (very broad s, 
NH3+), 8.96 (1H, d, J=8 .1 Hz, CONH), 11.4 (1H, broad s, 
NH-3). Elemental analysis. Found: C, 43.00; H, 4.08; N,
9.53%. Calculated for Ci9H 2i0 8N 4F • C 2F 30 2H • H 20 : C,
43.16; H, 4.14; N, 9.59%.
Peak II: [a] D 25 = -28.6 (c=0.07, H 20). NMR. 8 HD M S 0 _ d 6
2.8-3.2 (m, P-CH2), 3.9-4.0 (1H, m, H-4'), 4.0-4.3 (3H, m, 
a-CH, H-2', H-3'), 4.53 (1H, m, H-5'), 5.63 (1H, d, J=8.3 
Hz, H-5), 5.76 (1H, d, J=5.8 Hz, H-l'), 6.97-7.44 (4H, m, 
phenyl), 7.61 (1H, d, J=8.3 Hz, H-6 ), 8.83 (1H, broad d,
J=7.0 Hz, CONH), 11.38 (1H, broad s, NH-3). Elemental 
analysis. Found: C, 40.44; H, 3.94; N, 9.10%. Calculated 
for C 1 9H 2i08N 4F • 1.3 C 2F 30 2H . 2.2 H 20 : C, 40.52; H,
4.20; N, 8.75%.
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N- (4-Methoxvfumarovl)- l - 2 .3-diaminopropanovl-UPOC. 
rFMDP-UPOC). (121
N 2- (tert-Butoxycarbonyl)-N3-(4-methoxyfumaroyl)- l - 2 ,3- 
-diaminopropanoic acid was converted into the p-nitrophenyl 
ester by using dicyclohexylcarbodiimide in THF and 
crystallizing from ethyl acetate:ether. Yield: 75%. This 
product was homogeneous on silica thin layers using 
CH2Cl2/MeOH (8:2, Rf=0.80) as eluant. NMR 5HDMSO“d6 1.41 
(9H, s, tert-butyl), 3.68 (2H, m, p-CH2), 3.73 (3H, S, 
OCH3), 4.40 (1H, m, a-CH), 6.63 (1H, d, J=15.4 Hz, C=CH), 
7.02 (1H, d, J=15.4 HZ, C=CH), 7.41 (2H, d, J=8.9 Hz, 
ortho-phenyl), 7.58 (1H, d, J=7.5 Hz, OCONH), 8.34 (2H, d, 
J=8 .9 Hz, meta-phenyl), 8.82 (1H, t, J=5.7 Hz, p-NH). 
Boc-FMDP-ONp (104 mg, 238 umol) was coupled to UP0C*HC1 (70 
mg, 216 umol) in DMSO (2.16 mL) with added DIEA (75.3 uL, 
432 umol) by stirring at room temperature for 17 hr. The 
solvent was evaporated in vacuo to dryness, and the residue 
suspended and triturated in ether, and filtered. (Rf=0.32, 
l-butanol:acetic acid:water 4:1:2). The protecting group 
was removed by treatment with 2 mL of 2N HCl/dioxane, and 
93.1 mg of product were obtained (Rf=0.21, 1-butanol:acetic 
acid:water, 4:1:2, yellow color with ninhydrin spray). 60 
mg of this crude, product were purified by injection onto 
the Aquapore RP-18 column in 10 mg shots (solvent: TFA 
0.025%; flow rate, 4.50 mL/min). 12 mg of a s 98% pure
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fraction was obtained, as well as 26.5 mg of a s 95% pure 
fraction. Overall yield (coupling-deprotection- 
purification): 41%. [a]D25= +20.0 (c=0.11, H 20). NMR. 
SH D M S 0 " d 6 3.55 (2H, m, P-CH2), 3.73 (3H, s, OCH3), 3.94- 
4.26 (4H, m, H-2'-3'-4' and a-CH), 4.68 (1H, dd, H-5'), 
5.35 (1H, d, J=5.0 HZ, OH), 5.54 (1H, d, J=5.7 Hz, OH), 
5.67 (1H, d, J=8 .3 HZ, H-5), 5.78 (1H, d, J=6.0 Hz, H-l'), 
6.61 (1H, d, J=15.6 HZ, C=CH), 6.98 (1H, d, J=15.6 Hz, 
C=CH), 7.45 (1H, d, J=8.3 Hz, H-6 ), 8.24 (broad, NH3+), 
8.69 (1H, m, p-NH), 9.09 (1H, d, J=8.2 Hz, CONH), 11.44 
(1H, s, NH-3) Elemental analysis. Found: C, 35.76; H,
4.00; N, 10.16%. Calculated for Ci8H 2 30iiN5 • 1.5 C 2F 30 2H
. 2.6 H 20: C, 35,86; H, 4.26; N, 9.96%.
Biological Methods
Organisms: The following yeast strains were studied: c. 
albicans H-317, a clinical isolate from the Center for 
Disease Control, Atlanta, GA; c. albicans 124 and C. 
albicans 124 NikR, nikkomycin sensitive and resistant 
strains, respectively, from Dr. William Kingsbury, Smith, 
Kline and French Laboratories, Philadelphia, PA.
Chitin Synthetase Assay
Total chitin synthetase activity obtained in a mixed
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membrane fraction from C. albicans H-317 was assayed in the 
presence and absence of polyoxin compounds by measuring the 
incorporation of N-acetylglucosamine into chitin. The 
detailed procedures have been previously reported27,28.
Peptidase Assay
The procedures used to prepare a cell extract of C. 
a l b i c a n s H-317 in assays for hydrolysis of the antibiotics 
were previously reported). To assay for hydrolysis, TLC as 
well as HPLC were used. 0.5 mg of the antibiotic was 
dissolved in 50 uL of H 20:DMSO (50:50) and mixed at 36°C 
with 200 uL of cell extract (3.75 mg protein/mL). The 
mixture was incubated at 36°C, and at 20 min intervals 
small portions were withdrawn and directly chromatographed. 
Nle-UPOC9 was used as a control, and was completely 
hydrolyzed after 1 hr under these conditions.
Transport Studies
The procedures and transport conditions to assay for 
the uptake of labeled trimethionine and dileucine in the 
presence of polyoxin compounds have been previously 
described27,16. Cells of strain H-317 were harvested at 8 x 
106 cells/mL by centrifugation after growth in yeast 
nitrogen base with isoleucine (0.5%) as nitrogen source.
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After two washes with sterile distilled water, the cells 
were resuspended in 2% glucose and warmed at 37°C for 10 
min. An equal volume of cells was added to citric acid (10 
mM)-KH2P04 (lOmM) buffer at pH 3.5 with radioactive 
trimethionine (2.9 x 10-5 M, 1 pCi/pmol) 29 or pH 5.5 buffer 
with radioactive dileucine (5.6 x 10' 5 M, 44 pCi/pmol) 30 to 
a total volume of 1 mL. Analogs were added at 10-fold the 
molar concentration of the transport substrates for 
competition. At intervals of 0, 1, 2, 3, and 4 min, 180 pL 
of the reaction mixtures were withdrawn and applied to 
prewet filters (pore size 0.45 pm) and washed twice with 
2mL of cold distilled water. The filters were placed in 5 
mL of scintillation cocktail and counted. The rate of 
uptake was calculated as nanomoles of peptide taken 
up/milligram of dry weight cells per minute.
Determination of MIC
The methods and procedures employed for the 
determination of the MIC values in the presence of the 
polyoxin analogs have been described previously except that 
ammonium sulfate (0.5%) was used for most experiments as 
the nitrogen source27,16. The MIC was recorded as the 
lowest concentration of drug that resulted in 5% 
morphologically aberrant cells as visualized by microscopy 
after a 24-48 h incubation at 37°C in yeast nitrogen base
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(Difco Labs, Detroit, MI).
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Abbreviations used: DMF, dimethylformamide; DMSO,
dimethylsulfoxide; DSS, sodium 3-(trimethylsilyl)- 
-1-propanesulfonate; FAB, fast atom bombardment; FMDP, 
N 3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid; HOBt, 
hydroxybenzotriazole; ID50, concentration at which chitin 
synthetase is inhibited by 50%; MIC, minimum inhibitory 
concentration; lowest concentration that clearly inhibits 
growth; Nle, norleucine; NMM, N-methylmorpholine;
(oct)Lys-, N-€-(octanoyl)-lysyl; Oly, L-4-oxalysine; TFA, 
trifluoroacetic acid.
Table 7 Synthetic tripeptide chitin synthetase inhibitors
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‘Concentration at which chitin synthetase is inhibited by 50%. bMiniaua inhibitory concentration; lowest concentration of drug that clearly inhibited 
growth of strains H-317, 124 and 124N5 of C. albicans. c(+) conpound was hydrolyzed by C. albicans H-317 extract, (-) no hydrolysis by cell extract. 
'Percent inhibition of transport of (Leu)z or (Met)3 into C. albicans H-317. A 10-fold aolar excess of analogue was used in coaparison to the transport 
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Oxalysine 31 31 31
(d ,l )-m-F-phenylalanine >1000 >1000 >1000
FMDPb 7.8 7.8 15.6
aC. albicans strains H-317, 124, and 124N5 were grown in the presence 
of various amounts of toxic amino acid and their minimum inhibitory 
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Appendix A: Hydrolysis of nikkomvcin bv cell extracts from 
C_. albicans.
Polyoxin D has been shown to resist hydrolysis by 
intracellular peptidases from c.  albicans (61). This 
resistance to peptidases is necessary for the fungicidal 
action of the polyoxins, since the constituent amino acids 
are not chitin synthetase inhibitors. Nikkomycins are more 
toxic than the polyoxins and it is reasonable to expect 
that they would also resist enzymatic hydrolysis. There is 
no previous report in the literature about the stability of 
nikkomycins toward hydrolysis by fungal peptidases and we 
had to investigate this point. It has been mentioned at the 
end of Chapter I that nikkomycins X and Z are slowly 
degraded in a neutral aqueous solution at room temperature.
It is seen in Figures 5 and 6 that the negative slopes 
for the HPLC areas of nikkomycin X versus time are very 
similar when cell extracts are or are not present. The same 
is seen for the positive slopes of the degradation 
products. This indicates that nikkomycin X is not 
hydrolyzed by cell extracts from C. albicans.
During the non-enzymatic hydrolysis, half of the 
original nikkomycin is consumed in 44 hr., under the 
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Plot of concentration of nikkomycin X vs time. Numbers 
on vertical axis are areas of HPLC peaks. X, x: nik X 
with and without C. albicans cell extract. A, a: degra­
dation product(s) with and without cell extracts. 0.5 mg 
of antibiotic was dissolved in 250 uL buffer tris.HCl 
0.1 H, NaCl 0.1 M, pH 7.23 @ 20°C with or without cell 
extract and incubated at 37°C. 10 uL samples were injec­
ted onto an Aquapore spheri-5 RP18 column (22 cm x 
4.6 mm). The eluant was H20 with 0.1% TFA and with a 
linear gradient of MeOH from 0 to 10% in 30 min. The flow 
rate was 1.4 mL/min and the UV detector was set to 254 nm. 
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Figure 6 Plot of concentration of nikkomycin X vs time. 
Blow up of Figure 5.
-+25 hr
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Chapter IV. Conformational studies on nikkomycin X.
Solution studies.
The conformational study of nikkomycin X in aqueous 
solution is a first step toward understanding the molecular 
interactions of this antibiotic with the proteins which 
recognize it as a substrate (peptide permeases) or as an 
inhibitor (chitin synthetase). Once these interactions are 
understood, it should be possible to design a drug that 
would be translocated more efficiently into the cytoplasm, 
and/or that would be a better chitin synthetase inhibitor.
In 1984, Rathman et. al. (50) presented conformational 
parameters in DC1/D20 for the aminoacids nikkomycin C, [1- 
(S'-amino-S'-deoxy-p-D-allofuranosyluronic acid)uracil], 
and nikkomycin Cx, [1-(5'-amino-5'-deoxy-p-D-allofuranosyl 
uronic acid)uracil]. These two antibiotics are the carboxy 
terminus aminoacids of nikkomycin X and nikkomycin Z 
respectively (see Table 2, Chapter I). Using coupling 
constants 3J(C-2,H-1'), they deduced an anti conformation 
for both nucleosides, with an angle of the uracil ring 
plane x = 32° or 88° for nikkomycin C, and an angle of the 
imidazolinone ring plane x = 22° or 98° for nikkomycin Cx. 
They also calculated relative populations of rotamers of 
the exocyclic C-4' C-5' bond using proton-proton and
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carbon-proton coupling constants. For both antibiotics the 
trans (t) rotaxners were the most populated ones (70%). 
Finally, using the coupling constants of the ribose ring 
protons they calculated pseudorotational parameters and 
relative populations of types N and S conformers. They 
assumed a geometry for the S-type conformers identical to 
the one found in the crystal (50).
As a preliminary experiment for the study of the 
conformation of nikkomycin X in aqueous solution, 1H-nmr 
spectra of dilute samples of nikkomycin X («2.5 mg/mL) were 
run in water and different techniques for suppressing the 
immense solvent peak were tried. A closed capillary with 
D 20 was placed inside the nmr tube for signal lock. The top 
spectrum in Figure 7 was obtained without suppression. The 
presence of the water resonance introduced serious 
distortions associated with the high dynamic range of the 
spectrum, including inadequate analog-to-digital converter 
resolution, and computer memory overflow. The solvent 
resonance, with its first and higher order spinning 
sidebands, obscures most of the spectrum and severely 
distorts the baseline. The bottom spectrum (Figure 7) was
obtained by irradiating the sample with the 1331 sequence 
proposed by Hore (82), which is designed to selectively 
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Figure 7 200 MHz 1H-nmr spectrum of nikkomycin X, obtained
a) in H20; b) in D20; c) in H20 with the 1331 
pulse sequence. Reference: internal DSS.
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way it was possible to obtain a higher than 250-fold 
suppression of the solvent signal and observe exchangeable 
protons, such as the amide NH («8.95 ppm) and the 
imidazolinone NH-3 (ell ppm). These latter resonances 
cannot be seen in D 20 solution (Figure 7, middle spectrum).
Attempts were also made to suppress the water peak by 
irradiating the sample with a selective low power 
saturating pulse prior to pulsing and observation. This 
procedure, although straightforward to implement, runs the 
risk of saturation transfer by chemical exchange from the 
solvent to the solute spins. Indeed, even though the 
information that could be obtained in a run at pH 5.65 was
roughly the same as when using the 1331 sequence, the amide 
NH and the imidazolinone NH-3 resonances did not show up 
(data not shown). Therefore the saturating pulse technique
proved inferior to the 1331 sequence in this particular 
case.
The problems associated with the 1331 pulse technique 
were the following. First of all, the resonances within 
s0.6 ppm from the water peak could not be detected. This 
region includes both a-CHs and all the ribose ring protons 
except H-l'. Secondly, due to the limited spectral region 
that is excited, three independent runs were necessary in
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order to obtain a complete spectrum. Specifically, the 
bottom spectrum in Figure 7 is a composite of three 
separated spectra where the regions of interest were 
selectively excited by using three different sets of delays 
between pulses ( 0 . 7 ,  1 . 2 and 2.5 msec).
In the next section it will be shown how pH titration 
studies yielded information on the conformation of
nikkomycin X in aqueous solution. Since the 1331 pulse 
sequence allowed the monitoring of both exchangeable and 
non-exchangeable protons, it was the method of choice for 
carrying out those studies.
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Conformational studies of nikkomycin X in aqueous solution.
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Conformational Studies of Nikkomycin X 
in Aqueous Solution
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SYNOPSIS
Nikkomycin X  is a peptidyl-nucleoside antibiotic that inhibits chitin synthesis in fungi. 
Information on its conformation in aqueous solution was obtained from p H  titration studies 
in which the nmr shifts of exchangeable and nonexchangeable protons were monitored. 
These studies and nuclear Overhauser effects support an unfolded or conformationally 
flexible structure for the antibiotic, and the syn and anti conformations of the nucleoside 
moiety were found to coexist. The conformation of the ribose ring was determined using a 
two-state model; a slight shift from type N  to type S conformers occurred as the p H  was 
raised from 1 to 6.
INTRODUCTION
Nikkomycin X (also called neopolyoxin A; Figure 
1), a peptidyl nucleoside antibiotic produced by 
Streptom yces tendae, is a strong inhibitor of chitin 
synthetase from pathogenic fungi.1"3 This antibiotic 
is toxic to the zoopathogenic fungus Candida albicans 
only at relatively high concentrations, a fact that is 
very likely due to its poor binding and translocation 
into the cell by permeases.4,3
Determination of the potential conformations 
and flexibility of nikkomycin X  in aqueous solution 
is a first step toward understanding the molecular 
interactions of this and other related antibiotics with 
large membrane associated proteins such as peptide 
permeases and chitin synthetase. Previous analysis6 
of long-range coupling constants V (C -2, H -l') for 
the isolated carboxy terminus amino acid of nik­
komycin X [l-(5'-amino-5'-deoxy fi-D-allofurano- 
syluronic acid)-4-formyl-4-imidazoline-2-one] in 
DC1/D20  indicated that the nucleoside moiety has 
an an ti conformation, with an angle of the imidazo­
linone ring plane of X = 22° or 98°. The relative
©  1990 John Wiley &  Sons, Inc.
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populations of rotamers of the exocyclic C4'-C5' 
bond, as well as N- and S-type ribose conformers in 
DC1/D20 , were calculated using proton-proton and 
carbon-proton coupling constants.6
Since C. albicans grows well at a pH of approxi­
mately 4-4.5 while the cytoplasmic pH in yeast is 
very close to neutrality,7 we decided to study the 
conformation of nikkomycin X at different pH val­
ues. We therefore measured lH*nmr chemical shifts 
and coupling constants in the pH range from 1 to 
6. These titrations were carried out on dilute aqueous 
nikkomycin, using the 1331 pulse sequence proposed 
by Hore8 to generate the nmr spectra. Under these 
conditions the strong water resonance was barely 
excited and we were able to gain access to infor­
mation on exchangeable protons, such as the amide 
and the imidazoline NH resonances, without the risk 
of saturation transfer. Information on these ex­
changeable protons would not be available from 
samples run in D20 . We also explored the possible 
existence of a folded conformation of nikkomycin 
X by measuring nuclear Overhauser effects (NOEs) 
upon irradiation of the resolved proton signals.
MATERIALS AND METHODS
Nikkomycin X was purified as described previously9 
and obtained as a double trifluoroacetate salt. All 
nmr samples were 0.1 M  in KCi in order to avoid a


















Figure 1 The p H  titration shifts of some nikkomycin X  resonances at 25°C. The as­
signments are indicated on the right.
change in ionic strength upon addition o f  the titrants 
(0.1 N  HC1 or 0.1 N  N aO H ). T he concentration of 
nikkomycin X  was & 2.5 m g/m L . Sodium 3-(tri-  
m ethylsiiyl)-l-propanesulfonate (D S S ) was used as 
an internal reference, and a closed capillary con­
taining D20  was placed inside the nmr tube for signal 
lock. The reference D S S  has been shown to be es­
sentially independent o f  pH when compared to ace­
tone in D 20  (pH  1 -1 1 ) . ,0  Therefore no attem pt was 
made to  correct for possible pH-dependent shifts. 
‘H-nm r spectra at 200 M Hz were obtained on a 
Bruker spectrom eter equipped with an ASPECT  
2000A computer, at 25 ±  1 °C. T he temperature was 
controlled with a Bruker variable tempe;ature unit 
(V T U ) by passing heated air through the probe. The  
V T U  was calibrated before each run with an eth­
ylene glycol thermometer. T his consisted o f  a closed  
capillary containing ethylene glycol, inside a 5-mm  
ninr tube w ith DM SO-d«. T he separation in hertz 
between the m ethylene and hydroxyl proton reso­
nances was previously correlated w ith the temper­
ature by obtaining direct temperature measurements 
with a thermocouple at different VTU settings. W a­
ter suppression was achieved with a  1331 pulse se­
quence .8 T he transm itter pulse was attenuated (9  
db) and a net tip  angle o f  =; 45° was obtained with
a total 1331 pulse width o f 24 ps. T he delay between 
pulses was set at 0.7, 1.2, and 2.5 ms, in order to  
exam ine different regions of the spectrum. In each 
case, 2 0 0  transients were recorded and the relaxation 
delay was 8 . 0  s.
T he pH readings were obtained with a Radiome­
ter pH  meter, model PH M 82, using a combination  
glass pH  electrode (W ilmad, Buena, N J ) specially 
designed to fit into a 5-m m  nmr tube. Since the so ­
lutions were not buffered, the pH  was measured prior 
to and after the nmr runs, and the readings were 
averaged. In virtually all cases the variation in the  
pH was less than 0.05 pH units. T he titration curves 
reflect points obtained by first adding base until the  
pH rose to pH ~  6  and additional points obtained 
by back titrating w ith acid. Curve fitting of the t i ­
tration data was carried out with the regression 
analysis routine o f  the Lab One N M R  1 software 
from N ew  M ethods Research, Inc. (Syracuse, N Y ). 
T he iterative m ethod used is based on the Leven- 
berg-Marquardt algorithm . 11
Equilibrium NOEs were measured at 200 M Hz 
on the Bruker spectrometer and at 400 M H z on a 
JEO L spectrometer. Nikkom ycin concentrations 
were 4 m g /m L  at 200 M Hz and 8.5 m g /m L  at 400 
M H z in D 20  containing 0.10 M  KC1. Measured pD *s
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(m eter readings uncorrected for the isotope effect 
on the glass electrode) were 4.0 (a t  400 M H z) and
4.5 (a t 200 M H z). A t th is latter pD * the H -5 res­
onance was resolved from th e  hydroxypyridine res­
onances. Irradiation tim es o f 3.5 s (400 M H z) and
2.5 8  (200 M H z) were used, and all measurements 
were made at room temperature. In the run at 200 
M Hz the following precautions were taken in  pre­
paring the sample: D20  low in paramagnetic im ­
purities (Aldrich, Milwaukee, W I) (m inim um  iso­
topic purity 99.96 atom % D) was used; the glassware 
was washed with a solution o f  EDTA in D 20  prior 
to  use, and the final solution was subjected to  eight 
freeze-pum p-thaw cycles at 0.5 mm. H g under dry 
helium. The magnitudes and number of N O Es ob­
served were basically equivalent for both sets o f ex­
periments. Spectral analysis by computer simulation 
was carried out in som e cases (see the results and 
discussion section) with PANIC (a LAOCOON type 
program12) on the ASPEC T computer.
RESULTS AND DISCUSSION
T he different protons in nikkomycin X  produce t i ­
tration curves reflecting the deprotonation of acidic 
groups. In the sim plest case the curveB are described 
by the H enderson-H asselbach relationship:
pH = pKa +  log — (1)
wherein AH and A are concentrations o f protonated  
and deprotonated species, respectively.
W ithin the fast exchange condition, the chemical 
shift 6  is linearly related to the fractional populations 
o f  species A and AH:
6 =
A + A H 4a +
AH 
A + A H 4 a h
(2)
Table I ‘H-NMR T itration Param eters o f N ikkom ycin X in HaO
Proton *AH* A5b pKa' «/<Hz)
NH-3 1 1 .0 0 ±0.02d _ __
H-6 9.28 ±0.01* — —
C O N H 9.28 -0.61 2.95 ±0.05 7.0
H-6" 8.247 -0.189 4.341 ± 0.025 nd’
H-3"-4" 7.933 -0.520 4.353 ± 0.020 nd
H-5 7.675 +0.080 2.82 ± 0.06 (2.90 ± 0.04)h —
H-l' 5.654 -0.030 2.85 ±0.06 Jvr  = 5.09 ±  0.05'
H-4' 5.49 ±0.05' — 2.3*
H-5'1 4.751 nd nd Jf f =  3.62 ±  0.05'
H-3'1 4.621 nd nd J y = 5.45 ±  0.05'
H-2'1 4.521 nd nd Jyy  = 5.33 ±  0.05'
H-2'1 4.42' nd nd 4.6
H-4'1 4.351 nd nd —
H-3' 2.72 ±0.02* — —
Me-3’ 0.778 ±o.oor — 7.0
* Calculated chemical shift in parts per million from internal DSS in the fully protonated nikkomycin, 
or average 6 when the titration pattern was not simple or curve fitting was not attempted (see footnotes d 
and e). For samples run in DjO, observed chemical shift (see footnote i).
b Calculated Ai “ - im). ‘H-nmr titration shift in parts per million. Negative numbers indicste upfield
shifts upon deprotonation.
c Calculated pKa corresponds to microconstant pk,, within the assumptions referred to in the Appendix.
* The variation in i for NH-3 did not follow any discernible curve. It is likely that the true A5 is less than 
0.04 ppm.
* No simple titration, or curve fitting not calculated. The chemical shift varied within the limits indicated 
about average t.
'Not determined.
* Doublet broadened by “benzylic" long-range coupling to H-3”.
k Values in parentheses obtained when point at lowest pH is omitted from the correlation (see Figure 2 
and text).
1 Sample run in D sO at pD* 2.2.
























Figure 2 The p H  titration shifts of H-T, H*5, and H-6". The dashed line on the plot 
for H-5 is obtained when the point at lowest p H  is omitted from the correlation.
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Figure 2. (Continued)
Thus, Eq. ( 1 ) can be written as
pH  =  pK a +  iog -r— ^T  (3 )
fiA -  a
or rearranged to
, 6kh + 5a10,pH pK,) ...1 + io"’hpk,» ' ’
Equation (4 ) was used for nonlinear least-squares 
curve fitting o f the titration data, treating the pKa 
and the chem ical sh ifts o f the fully protonated ( 6 Ah ) 
and fully deprotonated species (iA = 5AH +  Ad) as 
adjustable parameters. In th is way we were able to  
determine pKa values to  better than ± 0 .1  pK a unit 
and to test the fit o f the data to the H enderson- 
H asselbach model. The titration curves are shown 
in Figure 1, and best-fit values for the parameters 
are given in Table 1 .
T he amide proton resonance shows an upheld t i­
tration sh ift o f  -0 .6 1  ppm. Intrinsic titration shifts 
(sh ifts th at arise from interaction w ith an ionizable 
group mediated only via covalent bonds) are always 
to  higher field upon deprotonation and have been 
shown to  be on the order o f  —0.3 to  - 0 .6  ppm for 
the amide proton o f  the C-terminal am ino acid res­
idue in som e short peptides . 13 In those studies the 
pKa for the titration curve was identical to  the pKa 
o f  the a-carboxyl group determined by 13C-nmr.u 
In the case o f  nikkom ycin X , w e found that the 
am ide proton titration data agrees well with a  curve 
generated by Eq. (4 )  ( Figure 1). T he calculated pKa 
for the ionization o f the carboxyl group of nikko­
mycin X  is  2.95 ±  0.05. As the pH is raised the amide 
proton resonance o f nikkomycin X  starts to  broaden 
due to  an increase o f the rate o f  exchange with the  
solvent, catalyzed by O H -  ions .16,16 The coupling 
constant for the doublet is no longer measurable at 
pH  5.15, and no attem pts were made to  run spectra 
above pH  6 .
T he protons o f  the pyridine ring show intrinsic 
titration sh ifts due to deprotonation o f  the pyridin- 
ium ion. These hydrogen atom s form an ABX system  
and the chem ical sh ift o f  the center o f  the AB por­
tion— H -3 ” and H-4™—in  addition to  the sh ift for 
the X  part—H -6 ™—are plotted in  Figure 1 . From  
both curves th e  sam e pKa value, 4.35, is obtained  
for the pyridine nucleus (T able I ) .
B oth  pK a values (carboxylic acid and pyndinium  
io n ) are in excellent agreem ent w ith previously re­
ported pK as .2 T he nearest additional ionizable group 
( a -N H j)  has a pK a = 7 .3 2 and therefore nikko­
mycin X  behaves as a diprotic acid over the pH range
1 0 1
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o f this study. As seen in Figure 1, deprotonation of 
the two acidic groups overlaps to a sm all extent (the  
pyridinium ion begins to deprotonate before car- 
boxylate formation is com plete). Equation (4 ) holds 
exactly for monoprotic acids or for stepwise depro­
tonation o f polyprotic acids. Nevertheless, it  can be 
used to  a  very good approximation for fitting our 
titration data for the following reasons: (a )  The  
chemical sh ifts o f the resonances studied show only  
one inflection point; they thus depend on the extent 
of protonation of only one o f the acidic groups, (b )  
Since the two acidic groups are far apart in the m ol­
ecule, the microscopic dissociation constant for one 
o f them  will not appreciably change i f  the other 
group is protonated or deprotonated ( see Appendix).
The imidazolinone proton H -5 and the ribose 
proton H -l'  show smaller titration shifts o f +0.08  
and -0 .0 3  respectively. Expanded titration curves 
are shown in Figure 2. The calculated pKa values 
for these curves are in good agreement with the pKa 
deduced from the amide titration (Table I ), and thus 
correspond to the ionization of the carboxyl group. 
For H-5 the correlation (and also the match o f  pK as) 
is improved if the point at lowest pH is omitted. 
This point (which shows the greatest deviation from 
the calculated curve) was obtained using a separate 
sample o f nikkomycin dissolved directly in 0.1 N  
HC1 without KC1 (see the materials and methods 






W e conclude, then, that the CONH, H-5 and H- 
1 ' sh ifts can be described by eq. (4 ) ,  with an inflec­
tion at the pKa o f the carboxylic acid. In the case 
o f H-5 and H -l', this implies an intramolecular 
through-space interaction between these protons 
and the carboxyl group. For direct interaction o f the 
carboxyl group and H-5 to  occur, the nucleoside 
m oiety has to  adopt a conformation in which the 
imidazolinone ring is anti (Figure 3 ) . Furthermore, 
the signs o f  the H -5 and H -1 ' titration sh ifts (Table 
1 ) can be rationalized on the basis of repulsion be­
tween the negative charge on the carboxylate anion  
and a electrons in the C-H bonds . 17 In the geom et­
rical arrangement expected for nikkomycin in an 
anti conformation, these interactions will tend to  
shield H - l ' and deshield H-5 from the magnetic field.
The possibility o f an indirect effect of the carboxyl 
group titration on H-5 when the imidazolinone ring 
is in the syn  conformation cannot be totally ex­
cluded. If the carboxyl group hydrogen bonds with 
the heterocyclic oxygen (oxygen on C -2), titration  
would affect th is interaction and m ight result in a 
change in chemical sh ift o f the H-5 resonance. N ev­
ertheless, we view th is possibility as unlikely since 
both H - 6  and NH -3 exhibited significantly smaller 
changes than H-5 upon titration o f the carboxyl 
group (T able I ) .  W e conclude that the titration be­
havior of H -5 supports the presence of an anti con­
formation for the heterocyclic ring. In any event the  










Figure 3  Conformations of imidazolinone nucleosides.
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boxyl group is situated above th e  plane o f  the ribose 
ring and close to  the imidazolinone heterocycle.
The imidazolinone N H -3 proton could only be 
observed between pH  2.0 and 3.5 as a broad reso­
nance at 11.0 ppm. A t other pH  values, a fast rate 
o f  exchange w ith the solvent, catalyzed either by H + 
(low pH  values) or by O H ' (high pH values), pre­
vented its detection. For other resonances observed, 
the titration sh ifts were much smaller (Table I ) and 
did not show a simple sigmoidal pattern.
The only ribose ring proton that could be observed 
during the titration experim ents in H 20  was H -l'. 
Resonances falling within 1 ppm o f  the water peak 
(other ribose ring protons, H-5', H-2", and at high 
pH  values H -4 ')  could not be detected using Hore’s 
sequence. W hen nikkomycin was run in D 20  at pD  * 
2 .2 , all the ribose protons were resolved at 200 MHz. 
Computer sim ulation o f  the ribose ring portion of  
the spectrum at pD * 2.2 gave som e o f the parameters 
shown in Table I.
The conformation o f ribose rings can be described 
unequivocally by the puckering amplitude (ra ) and 
the phase angle o f  pseudorotation ( P ) . I0  In nucleo­
sides and nucleotides in solution, the furanose ring 
is  engaged in a conformational equilibrium described 
by N - and S-type conformers (Figure 3) . ,0  An exact 
treatm ent o f  a tw o-state model is  not possible, since  
only three observables are available from the nmr 
experim ent (Jyy, Jyz, and Jyv) whereas the con­
formation in  solution is fully described by five pa­
rameters (P Nt t n , P s , rg, and the mole fraction of 
N-conformer X n ), resulting in an underdetermined 
system . Nevertheless, an approximate approach is 
possible , 19 in which Jyy is assumed to have the same 
value for the two "pure” conformers and the sum  
J i ‘y  + J 3<f is  assumed to  be practically independent 
o f  the magnitude o f  the equilibrium constant. A 
classical Karplus-type two-parameter equation20 is 
used for the calculations. T he above assumptions, 
as well as the derivation o f  the Karplus parameters, 
rely on geometrical considerations in the solid state  
for an extensive set o f  nucleosides and nucleotides. 
In this way a fairly accurate value o f Xn can be ob­
tained, as well as estim ates o f the remaining param­
eters. (For possible alternative treatments, see Refs. 
2 1  and 2 2 ).
According to  the above treatm ent, we obtained 
at pD* 2.2, t n = 35°, P N =  16°. rs =  37.5°, Pg 
= 165.5°, and X n *= 0.50. Therefore there is  n o par­
ticular preference for either the N - or S-type con- 
former at pH  2 .2 , and the values o f  the phase angles 
fall within the preferred pseudorotational regions 
for ribose nucleosides .10
Inspection o f  the H - l'  resonance throughout the
titration experim ent reveals that J i <y gradually in ­
creases with the pH , from a value o f 4.3 H z at pH  
1 .0 , to  5.9 H z at pH  5.85 (Figure 4 ) .  However, the  
J i *2' values are based on a first-order analysis o f  the 
spectra, since the other pentoBe resonances are bur­
ied under the water peak. T o  analyze the putative  
effects o f higher order sp in -sp in  interactions on  
J-i'T, we sim ulated nmr spectra run in D20  at pD*  
-  2.2 ( 200 M Hz, see above and the m aterials m eth­
ods section ) and a t pD * =  4.0 (400 M H z), and used  
these to  calculate coupling constants for the ribose 
protons. A t pD* =  4.5 and 200 M Hz the spectrum  
of nikkomycin was com plicated by overlap of H -3' 
and H -5' and second-order coupling interactions. 
The higher magnetic field (400 M H z) led to  signif­
icant spectral simplification. The coupling constants 
at pD* = 2.2 are listed in Table I. A t pD* =  4.0 
they were J y y  = 5.75 ±  0.08 Hz, J 2-y =  5.34 ±  0.08  
Hz, J 3’4‘ =  4.65 ±  0.08 Hz, and J y y  = 4.04 ±  0.08  
Hz. As seen in  the p lot in Figure 4, the calculated  
Ji  >2 'S are slightly higher than the observed ones at 
both low (2 .2 ) and high (4 .0 ) pD* values. T his sup­
ports our conclusion that the true coupling constant 
does increase with the pH. Our interpretation, based 
on the approxim ation19 X n =: 1 -  0.10 X J ,-y ,  is  
that the variation shown corresponds to  a sh ift o f 
the conformational equilibrium from X n =  0 . 6  to 
Xn =  0.4 as the pH  increases from 1  to  6 .
T hat J t increases from 3.62 ±  0.05 Hz at pD*  
2.2 to 4.04 ±  0.08 H z at pD * 4.0 indicates that the 
sh ift o f  the equilibrium from N - to  S-type conform­
ers is accompanied by rotational changes along the 
C4’-C5’ bond. Previous studies in both solution and 
the solid state have also found a correlation between  
the nature o f  the ribose ring puckering and the con­
formation o f  th e  CH 2OH group in pyrimidine nu­
cleosides . 19,23
T he coupling constant «/nh-«>ch did not vary from 
pH  1 to  5 (T able I ) ,  indicating that there are no 
significant conformational changes along the N -aC  
bond. Its value o f 7.0 H z is close to the m ean value 
for N H -aC H  coupling constants in  peptides24 and  
suggests conformational freedom for th is particular 
bond (seeb e lo w ).
N O E s are displayed in Figure 5. Due to the size 
o f  th e  m olecule, the contribution to the relaxation 
processes from the double- and zero-quantum path­
ways are approximately equal in magnitude, and the  
N O Es detected are therefore small and positive. B e­
cause the email size o f  th e  N O E s m akes two-dim en­
sional N O E experim ents (N O E SY ) impractical, 
one-dim ensional experim ents were run, using long  
irradiation tim es (2 .5 -3 .5  s ) in  order to  obtain m ax­







Figure 4 Plot of«/, <2> vs pH, at 25°C. Open circles represent data obtained by first-order 
analysis from spectra run in H 2O. Solid circles represent points obtained by computer 
simulation of spectra run in D aO.
tances by measuring initial slopes o f  the tim e de­
velopm ent of N O Es were not attem pted due to the  
signal-to-noise problem at Bhort tim es. There were 
no through-space interactions between hydrogen
atom s o f  the two amino acids, although NO Es be­
tween hydrogen atom s within a given am ino acid 
were observed. W e conclude that nikkomycin X  is 
conformationally flexible in water and that there is
OH
Figure 6  NOE measurements on nikkomycin X  (8 .6  mg/mL) in DjO, at 400 MHz. The 
solution was 0.10 M  in KC1 and the pD* was 4.0. Arrows go from irradiated to enhanced 
protons. Numbers are NOEb percent relative to the intensity of the saturated peak in the 
difference spectrum.
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no detectable stabilized folded conformation. The  
NO Es observed between H -5 and H-2', and H -5 and  
H-3', support the existence o f  an anti conformation  
in  the nucleoside moiety. Surprisingly, N O E s were 
measured between H -5 and H -l'  (Figure 5 ) . Cal­
culations carried out on a closely related uracil nu­
cleoside have demonstrated M that a measureable 
NO E between H -5 (H - 6  in uracil) and H -l'  is not 
expected for the anti conformer, and thu s our result 
shows that the syn  conformation is significantly 
populated as well. T he existence o f  the syn  confor­
m ation is in contrast to  previous reports6 that have 
indicated the conformation o f the carboxy term inus 
am ino acid o f  nikkomycin X  in  aqueous solution to  
be anti. Nevertheless, these latter studies6  were 
based on coupling constants and the calculated con­
formation m ight be a weighted average o f  popula­
tions w ith very different angles o f the imidazolinone 
ring plane (X ).
CONCLUSION
The following conformational changes were detected 
during the titration of nikkomycin X  from pH 1 to  
6 : a sh ift from N-type ribose to  S-type o f approxi­
mately 2 0 % upon deprotonation and rotational 
changes along the C 4-C 5' bond. T he titration data 
supports the existence o f a conformer with the car- 
boxylic group above the ribose plane and the im id­
azolinone ring in an anti position, whereas there is 
evidence from the NO E experiments that both the  
anti and syn  conformations are populated. N o  NOEs 
could be detected between protons o f  the two am ino  
acids, and th is supports an unfolded or conforma- 
tionally flexible structure for nikkomycin X  in  
aqueous solution. These studies define the solution  
conformation o f nikkomycin and provide a basis for 
the exam ination o f  th is molecule bound to  chitin  
synthetase or the peptide permease o f C. albicans.
APPENDIX
A diprotic acid ionizes according to  the following 
scheme:
H,AH, ^  AH;
Ol * H*."Jl
H ,A ^  A
where k,-, kj, and %■,• are the microscopic acid d is­
sociation constants, and the subscripts i and j  in ­
dicate the protons on acidic groups i and j . K The  
m icroconstants are defined as
AH; X H , H .A X H  
1 H,AH; : ' H.AH; :
A X H  
AH, ;
A X H  
H,A
( A l)
For a  unique resonance (a  resonance with a chemical 
sh ift dependent on the degree o f protonation o f  only 
one o f  the acidic groups, say group i ) , the observed 
chem ical sh ift [compare to  Eq. (2 ) ]  is
(A 2)
where and are the fractional protonation and 
deprotonation o f group i, and 6^, and the chemical 
sh ifts o f  species with group i fully protonated and 
fully deprotonated for that particular unique reso­
nance .86 Since (/tp + /td ) =  l,E q . (A 2) can be written
Therefore,
5 5i,p _ /i.d 
^i,d — i  fi, p
6  -  6 ^  A +  AH; 
d -  « ~  H,AH; +  H,A
(A 3)
(A 4)
Substituting Eqs. ( A l)  into Eq. (A 4) and taking 
logarithms, gives




W hen kjj a: kj, the last term vanishes and Eq. 
(A 5 ) is  formally analogous to  Eq. (3 ) .  Since  
= kjkji, the condition a  kj is  equivalent to k, a  A,, 
and m eans that an acidic group i will dissociate with 
the sam e dissociation m icroconstant whether the  
acidic group j  is protonated or not. T hat is a rea­
sonable assum ption if  groups i and j  are far away 
from each other in  the molecule and cannot interact. 
N otice also that the pKa being measured with the  
model used in th is study [Eq. (4 ) ]  corresponds to  
the m icroconstant pk,.
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Appendix B; Conformation of the ribose ring of nikkomycin 
X.
As Altona et al. have shown (83), the conformation of 
ribose rings can be described unequivocally by the 
puckering amplitude (xm) (or maximum angle of torsion) and 
the phase angle of pseudorotation (P). According to their 
treatment, the endocyclic torsion angles about the bonds 
C(l')-C(2'), C(2')-(3'), (3')-C(4'), C(4')-0(4'), and 
0(4/)-C(l/),denoted x l f  t 2 , x 3 , x 4 , and x 0 respectively, 
are related to xm and P by the pseudorotation equations 
(84):
tl = ^mCOS(P - 144°) 
x2 = xmcosP 
t3 = xmcos(P + 144°) 
x 4 = xmCOS(P + 288°) 
x 0 = + 72°)
As the molecule completes a full pseudorotational cycle, P 
goes from 0° to 360° and the dihedral angle x2 passes
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through the values Tm, 0°, -xm, 0°, and tm again. The 
torsion angle x3 moves in the same way, but with a phase 
shift of + 144°, x4 with a phase shift of + 288°, and so 
on.
In cyclopentane the phase angle P rotates without 
significant change in potential energy. However, in 
ribonucleosides, the presence of endocyclic and exocyclic 
substituents gives rise to an energy barrier that opposes 
free pseudorotation. The authors (84) called type N 
conformers those with conformations occupying the northern 
half of the pseudorotational circle (P = 0 ± 90°), and type 
S conformers the ones that occupy the southern half of the 
pseudorotational circle (P = 180 ± 90°). Based on X-ray 
data for 60 nucleosides, they showed that p-purine and 
p-pyrimidine ribosides prefer two narrow pseudorotational 
ranges, each occupying less than 10% of all the possible 
values of P (0 to 360°). Thus there is a type N potential 
energy well for p-pyrimidine sugars with values of P 
ranging from 2 to 25°, and a type S energy well with P of 
161 to 175°. Although in the solid state either the N or 
the S type conformers are found, in solution both 
conformers are assumed to be present in dynamic 
equilibrium. The observed 1H-nmr parameters in solution can 
be fully explained by this two-state dynamic conformational 
equilibrium model (83).
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Figure 8 Two ribose ring conformers of nikkomycin X in 
aqueous solution. At pD* 2.2, the population of 
each conformer is 50%.
The following parameters were deduced, for nikkomycin X 
from proton-proton coupling data in D 20 solution at pD* 2.2 
(see previous section):
tN= 35° ; PN= 16° ; x s= 37.5° ; P s= 165.5° ; XN= 0.50 
The two conformers in equilibrium are shown in Figure 8
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Based on the observed change of Ji>2> with the pH, it 
was also shown in the previous section that the 
conformational equilibrium shifts from XNs 0.6 to XN« 0.4 
as the pH increases from 1 to 6. This change is accompanied 
by rotational changes along the C4'-C5' bond. It was 
necessary to prove that the change in J i ■2 > was not due to 
high order spin-spin interactions, and spectra run at pD* = 
2.2 and pD* =4 . 0  were simulated using PANIC (a LAOCOON 
type program (85)) on an ASPECT 2000A computer (IBM). The 









J1(2,=5.09+0.05 J2 ,3 ,=5.33+0.05 J3,5,=-.02+0.05
Jlt3,=-.12+0.05 J2,A ,=-.12±0.05
J11A,=0.03+0.05 J2,5 ,=0.01+0.05
Jr 5 ,=0.01±0.05 J3,a ,=5.A5+0.05









Figure 9 Ribose region of nikkomycin X. a) 200 MHz^H-nmr spectrum in D20, pD*-2.2
(DSS internal reference), b) A sine bell multiplication and then zero filling 
was applied to FID of spectrum (a) before FT in order to enhance the resolution, 
c) Simulated spectrum. Calculated parameters are shown in upper panel,


















j 3 , 4 i = 4 . 6 5 ± 0 . 0 8
J3-5-='*02±0-08
• V 5 . ^ - 04±0*08
Ribose region of nikkomycin X. a) 400 MHz-1H-nmr spectrum in D20, pD*-4.0 
(DSS internal reference), b) A sine bell multiplication and then zero filling 
was applied to FID of spectrum (a) before FT in order to enhance the resolution, 
c) Simulated spectrum. Linewidth: 4.7 Hz (lorentzian). Calculated parameters 
for this spectrum are shown at right, d) Sine bell multiplication and zero 
filling were applied to simulated FID and then FT in order to simulate spectrum (b). 
W (chemical shifts) and J in Hz. Horizontal axis corresponds to spectrum 
(b) only. The ribose protons are indicated above the resonances.
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Transferred nuclear Overhauser effect.
The nuclear Overhauser effect (nOe) is a change in the 
intensity of an nmr signal when the transitions of another 
one are perturbed. The perturbation of interest is the 
saturation of the particular nmr resonance. tii(s) is the 
nOe at nucleus i when nucleus s is saturated, and occurs 
due to cross relaxation (simultaneous transitions of two 
spins) between nuclei. For a two-spin system relaxing via 
dipolar coupling,
W -  V„i(. )  h — ^
* ou i2V + V2 + vo
where W 2 and W 0 are the rate constants for the double and 
zero quantum transitions respectively, and Wi* is the rate 
constant for the single quantum transition of nucleus i. 
The strength of the dipolar interaction depends on the 
internuclear distance. The numerator in the above equation 
is the net cross relaxation of nuclei i and s
o i s  ■ w2 -  Wo
and the denominator is the total relaxation for nucleus i
Pi  a 2 W ! 1 +  W2 +  W0
If we have an inhibitor or small ligand, I, 
interacting with an enzyme E, generally a protein of much 
higher molecular weight,
it is possible that information relative to the cross 
relaxation between two protons in I can be transferred from 
the bound (IE) to the free state by chemical exchange. In 
such case, irradiation of free I protons will result in 
negative nOes in other free ligand protons, yielding 
information about the proximity in space of nuclei in the 
bound ligand (8 6 ). The use of the transferred nOe (trnOe) 
does not require that the proton resonances of the protein 
(or eventually the resonances of the bound ligand) be 
resolved, extending its usefulness to the study of the very 
largest systems (8 6 ).
A theoretical study of the dependency of the observed 
trnOe on the relevant parameters has been carried out by 
Clore e t  a l . (8 6 ). The parameters are: the rate constants 
of chemical exchange, the expected nOes in the absence of 
chemical exchange, the relative concentration of free 
ligand to protein, the total spin-lattice relaxation rates 
of the free and bound ligand resonances, and the molecular 
weight of the protein. It is shown that in general, in the 
slow chemical exchange limit on the spin-lattice relaxation 
time scale of the free ligand (ki[E] + k_i < pif)/ attempts 
to obtain structural information on the bound ligand by 
measuring trnOes will be fruitless (except in special
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cases). Conversely, in the fast chemical exchange limit 
(ki[E] + k_i > 10piF), trnOes can be used for obtaining 
information on the bound state, provided a negative trnOe 
is observed. Thus, for large proteins it is feasible to use 
large excess of ligand and still obtain substantial 
negative nOes and therefore useful conformational 
information. Structural information of a quantitative 
nature can be obtained from the trnOes by measuring their 
initial build-up rates (87). Attempts to observe trnOes on 
nikkomycin X in the presence of yeast membranes containing 
active enzymes are described in the next section.
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Studies in the presence of active enzymes.
An understanding of how nikkomycins interact with 
chitin synthetase and peptide permeases may lead to the 
rational design of analogs with improved biological 
properties (for instance increased inhibitor activity, or 
increased permeability). The trnOe method has been used 
recently to determine the conformation of various 
enzyme-bound ligands (88,89) and agonists bound to 
receptors (90). it may be possible, in principle, to 
isolate chitin synthetase from c. albicans and carry out 
trnOe measurements on its inhibitors. Pure chitin 
synthetase in its active form has been isolated in an 
ingenious way (co-precipitation with its product) from 
another yeast, Saccharomyces cerevisiae (13).
In order to investigate the feasibility of trnOe 
experiments with pure c.  albicans enzymes, nOe measurements 
on nikkomycin X in the presence of c. albicans membrane 
fractions containing activated chitin synthetase (the same 
membrane preparations used for the chitin synthetase 
inhibition assays described in Chapter III) were performed. 
Those preliminary experiments are described here.
EXPERIMENTAL PROCEDURES
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Mixed membrane fractions from various strains of 
Candida albicans and from Schizosaccharomyces pombe were 
obtained in the same way as described for chitin synthetase 
assays (see Chapter III, third section), with slight 
modifications. Phosphate buffer in D 20 (99.996 % D,
Aldrich, Milwaukee, WI) was used in order to avoid 
interferences in the nmr spectra. The following reagents 
(at the specified concentrations) were present in the 
enzyme preparation during the measurement of activity as 
well as during the nmr experiments: K 2HP04 , 30 to 60 mM; 
EDTA, 0.06 mM; DTE, 0.16 mM; MgCl2 , 6.2 mM; GlcNAc, 3.2 
mM. For the nmr runs, the above reagents had been 
previously freeze-dried twice from deuterium oxide in order 
to replace the exchangeable protons. The pD* of the buffer 
was adjusted to a value of 6.45 with DC1/D20. The buffer 
was microfiltered (0.4 urn) before use. In contrast to 
enzyme preparations used previously for chitin synthetase 
assays (see Chapter III), the ones studied here lacked ATP. 
Chitin synthetase was activated with trypsin (0.04 mg/mL) 
at 37°C for 10 min, and then STI (0.06 mg/mL) was added. 
These two soluble proteins were eliminated from the sample 
by centrifuging at 20,000 rpm (4°C) 50 minutes and 
replacing the buffer three times.
Lipid vesicles and lamellae were prepared by 
suspending L-a-dipalmitoylphosphatidylcholine, chain
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deuterated (DPPC-d6 2 • obtained from Cambridge Isotope 
Laboratories, Woburn, Massachusetts) in phosphate buffer 
(pD* 6.45 ) in a glass vial. A few small glass beads were 
added and the suspension was vortexed for approximately one 
minute. In order to prepare the vesicles, the sample was 
transferred to a polypropylene vial and sonicated with a 
Heat Systems W-380 Sonicator, according to the procedure of 
Barrow et al. (91). The water bath temperature was 
maintained 10°C above the lipid phase transition 
temperature (Tcss 41 °C) and sonication was continued up to 
the point where the sample was almost clear. This required 
less than an hour. The sample was then centrifuged for 15 
minutes at 1 0 , 0 0 0  rpm in a microcentrifuge in order to 
remove large and multilamellar vesicles, and was stored at 
room temperature. The vesicle diameters were around 1500 A, 
(p/7 2 =0.3), as determined by guasielastic light scattering 
measurements using a Lexel Model 65 Argon-Ion Laser and 
Langley Ford Model 1096 correlator.
Nmr experiments were performed at 200 MHz on a Bruker 
spectrometer equipped with an Aspect 2000A computer. All 
experiments were run at 300°K. NOes were measured by using 
the following pulse sequence: [RD-preirradiate(t,ci) 
-observation pulse]8n for a list of frequencies w. RD, the 
relaxation delay, was set to 7.0 sec; t, the duration of 
the selective proton preirradiation, was varied from 0.50
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to 3.0 sec for different samples. The duration of the 
observation pulse was adjusted for a tip angle of 90°. The 
nOes were observed by substraction of a control FID 
(obtained by off-resonance preirradiation) from the 
experimental FID, multiplication of the difference FID by a 
decaying exponential, and then Fourier transformation. The 
magnitudes of the nOes were determined by peak height 
measurements.
RESULTS AND DISCUSSION
When a 1H-nmr spectrum of a membrane fraction from
Candida albicans H-317 (16 mg protein/mL) containing active
chitin synthetase was run at 200 MHz, only a few broad
peaks were seen (Figure 11, trace b). Methyl groups and
other resonances were observed at high fields, whereas no
resonances were seen in the region from 5.5 to 11 ppm. When
nikkomycin X was added (8 mg/mL) most of the antibiotic
resonances, although broadened, could be observed (see
trace c). When a nikkomycin resonance, such as H-5, was
irradiated, negative nOes were observed (trace e). This is
*
in sharp contrast to nOes observed in the absence of the 
enzyme-containing membranes, which were positive (see 
previous section, and trace d). The negative nOes strongly 
suggest that it is the enzyme-bound antibiotic which was 









Figure U  1H-nmr spectra in D20 of (a) Nikkomycin X, and (b) membrane fractions from Candida 
albicans H-317 containing chitin synthetase; (c) Nikkomycin X plus the membrane 
fractions; (d) NOe difference spectrum, same conditions as in (a), H-5 irradiated 
(3 sec); (e) NOe difference spectrum, same conditions as in (c), H-5 irradiated 
(500 msec). This figure appears in reference [92]).
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the solution viscosity were responsible for the change in 
the sign of the nOes. Furthermore, it is also conceivable 
that nikkomycin binds non-specifically to lipids or to 
membrane proteins unrelated to chitin synthetase.
An ideal control experiment would necessitate 
membranes from a strain of C. albicans unable to synthesize 
chitin. Since such a hypothetical strain is not viable, we 
ran control experiments which consisted of measuring nOes 
for nikkomycin in the presence of DPPC vesicles (16 mg/mL), 
DPPC lamellae (16 mg/mL), or DPPC vesicles plus BSA (16 
mg/mL of each). These lipids and protein mimic the cellular 
components found in the membrane fractions of C. albicans, 
probably generating a sample of comparable viscosity. In 
all the control experiments the signs of the nOes were 
identical to those obtained for free nikkomycin in 
solution. These results are displayed in Table 10 (three 
last columns), and support the conclusion that the negative 
nOes observed in the presence of membrane fractions provide 
conformational information on nikkomycin bound to chitin 
synthetase.
It is possible that the above membrane fractions from 
c, albicans contain peptide permeases, and that these 
proteins are still operative. In that case, they would 
interact with nikkomycin and possibly yield negative nOes.
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Membranes









Buffer (mM) 0 31 62 62 62 25 50 50
Protein
(mg/mL) 0 16 90 88 160 0 16 0
Activity 
(nmol/mg.mln] (nmol/mL.min]
00 0.9515.2 0.2522.5 0.2522.0 00 00 00 00
Nikkomycin
(mg/mL) 3.9 8.0 8.0 8.0 26.2 7.8 8.0 8.0 8.2
pD* 4.5 4.4 4.1 4.6 4.8 4.6 2.9 4.3 2.5
irradiation 






+5.8 -8.4 -3.2 -6.3 -5.1 -12.5
-2.4
positive positive f4.S +1.9
H-6'" Py-4-3
He-3"























































































n.d. n.d. n.d. n.d. n.d. n.d. n.d.
H-4’ H-l' +8.4 negative n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Table 10 Results of nOe experiments at 200 MHz on nikkomycin X in the
presence of yeast membranes or lipid vesicles. Solvent: buffer 
phosphate in D20. Temperature: 300°K. The magnitudes of the 
nOes were determined by peak height measurements.
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NOe experiments in the presence of membranes from c. 
albicans 124N5, a nikkomycin resistant mutant lacking a 
dipeptide transport system were run. Those membranes are 
not expected to have permeases able to interact with 
nikkomycin. Membranes from the corresponding wild strain,
C. albicans 124, were used as control. Conversely, membrane 
fractions from Schizosaccharomyces pombe, a yeast believed 
to lack chitin synthetase, were used in parallel nOe 
experiments. The results of all these experiments are 
summarized in Table 10, and the nOe experiments with s, 
pombe membranes are shown in Figure 12.
The nOes in the presence of the nikkomycin resistant 
mutant were negative, suggesting an interaction with chitin 
synthetase. It was observed in this nmr run that the 
H-3'''-4'" signal did split ca. 0.3 ppm, whereas the 
H-6'" signal was split 0.18 ppm (data not shown). When the 
amount of nikkomycin was increased more than 3-fold, no 
significant change in the magnitude of nOes was detected 
(Table 10), but the split signals collapsed into the 
expected pattern. At this point we are unable to give a 
satisfactory explanation for the splitting of the pyridine 
signals.
In the experiment with s. pombe membranes, negative 
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Figure 12 1H-nmr spectra in D20 of (a) Membrane fractions from Schizosaccharomyces pombe; (b) plus
nikkomycin X. (c) to (i) NOe difference spectra with various resonances irradiated. (For
experimental conditions, see Table 7). Magnitudes of nOes are indicated next to peaks.
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this yeast's growth is inhibited at very high 
concentrations of nikkomycin and it is therefore possible 
that chitin synthetases are present in the membranes. In 
addition to the nOes seen with other yeast membranes, an 
extra set of small negative nOes was observed (Table 10 and 
Figure 12). Many of those nOes, if they are primary nOes, 
could indicate folding of nikkomycin. However, some degree 
of spin diffusion seems to have occurred in this particular 
experiment. Thus, it is very likely that the nOe from CHO 
to H-l' was mediated by H-5, since the spatial relationship 
between H-l' and CHO would preclude direct dipolar 
interaction. The appearance of spin diffusion in this 
experiment could be due to the higher concentration of the 
membranes (Table 10), or possibly to the different sizes of 
the cellular components.
CONCLUSION
The above experiments are preliminary and they raise 
more questions than they answer. We cannot at this point 
distinguish clearly between a fast chemical equilibrium or 
a viscosity effect as the cause for the negative nOes 
observed in the presence of membranes. The positive nOes in 
the experiments with lipids suggest the chemical 
equilibrium hypothesis to be the correct one, but this 
cannot be conclusive. We think that this question can be
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addressed by using a viscosity probe, a small molecule 
which should not interact with the membranes and on which 
nOes can be measured. If positive nOes are observed in the 
presence of membranes, the viscosity effect can be ruled 
out as a cause for the negative nOes in nikkomycin. Amino 
acids from the d-series would be suitable candidates for 
these experiments since they are not expected to interact 
with the membranes.
If transferred nOes are being measured, it will be 
necessary to get an estimate of the exchange rate, in order 
to know if quantitative structural data can be extracted 
from those measurements. On the other hand it is important 
to determine whether small nOes that could indicate 
folding, such as some of the ones observed with S. pombe 
membranes, are primary or due to spin diffusion. This can 




This thesis has described a combination of synthetic 
and spectroscopic approaches to design improved inhibitors 
against C. albicans. A novel mode of chromatography was 
devised and used successfully for the separation and 
purification of nikkomycins X and Z. The conditions for the 
coupling of amino acids in the synthesis of nikkomycin and 
polyoxin analogs were optimized. Some of the synthetic 
analogs behaved as prodrugs but had low toxicity against C. 
albicans . Although the drug design strategies described 
deserve further exploration, it was found that the 
structural specificity for peptide transport in this yeast 
is more complex than previously thought and the 
permeability of new antibiotics cannot be predicted with a 
reasonable degree of certainty.
The spectroscopic studies showed nikkomycin X to be a 
very flexible molecule in aqueous solution and defined the 
configuration of the ribose ring and the relative spatial 
orientation of the imidazolinone heterocycle. Attempts to 
measure trnOes for this antibiotic in the presence of yeast 
membranes containing chitin synthetase resulted in data 
that was very difficult to interpret due to the complexity 
of the system and to the absence of a good control. It 
would be of great interest to run nOe experiments on
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nikkomycins in the presence of purified chitin synthetase 
and of purified peptide permease. Such experiments should 
shed important structural information on the interaction of 
chitin synthetase inhibitors with critical components of 
the candidal cell membrane.
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